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Abstract:  
 
Coronary heart disease (CHD), characterized by degenerative changes in coronary 
circulation, is the leading cause of death in the US. Vascular wall endothelial cells (EC) 
and circulating blood platelets play a major role in pathogenesis of CHD. The normal 
functions and activities of EC and platelets can be significantly affected by blood flow 
induced shear stress.  The major goal of this study was to estimate shear stress 
environment in the human left coronary artery using a computational fluid dynamics 
model, and to examine the effect of physiologically relevant dynamic shear stress on 
endothelial cells, platelets and their interaction. In this study, numerical simulations were 
conducted using a physiologically realistic left coronary artery 3D model under normal 
and disease (stenosis) conditions. The results indicated highly disturbed flow patterns 
under stenosis conditions. The dynamic shear stress waveforms (physiological and 
pathological) from numerical studies were applied to EC and platelets using a cone and 
plate shearing device, or a parallel plate flow chamber. Pathological shear stress (low and 
high) could significantly affect EC activation. For platelets, pathological shear stress 
induced significant changes in platelet proteome profiles, and caused complement 
activation. However, when platelets and EC were exposed to the same dynamic shear 
stress simultaneously, both EC and platelet response to shear stress changed. Pathological 
shear stress failed to activate EC, or lead to platelet complement activation.  Further, 
when EC and platelets were sheared simultaneously, platelet adhesion to EC monolayer 
was observed, especially under low pulsatile shear stress. Together, the results suggest 
that platelet-EC interaction could protect EC and platelets from dynamic pathological 
shear stress, and it is potentially through physical contact between platelets and EC, i.e., 
platelet adhesion to EC. Further investigation is needed to identify mediators in this 
protective mechanism, which may lead to new therapeutic solutions to atherosclerosis 
and coronary artery disease.   
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CHAPTER I 
 
 
INTRODUCTION 
 Coronary arteries supply blood and oxygen to the heart muscles. Degenerative 
changes in the coronary circulation affect blood supply to the heart muscles and result in 
coronary heart disease (CHD). CHD is the leading fatal disease in the US (17.6 million 
deaths in 2008), accounting for nearly 50% of all cardiovascular disease (CVD) deaths 
(shown in Figure 1)
1
. Atherosclerosis is the single most common reason behind CHD, 
and most other CVDs. A characteristic feature of this vascular inflammatory disease is 
the localization and growth of atheroma/plaque, which reduces the lumen size of a blood 
vessel. The changes in endothelium (innermost layer of blood vessel) may result in an 
increased adhesion and trans-endothelial migration of lipids and leukocytes. The 
continuous deposition at the sub-endothelial layer induces inflammatory responses and 
results in plaque formation. Atherosclerosis in the coronary circulation alters the blood 
flow to the downstream region, which may result in an acute condition referred to as 
myocardial infarction.   
In general, regions of complex blood flow are usually predisposed locations for 
anchoring of atherosclerotic lesions. The complex vascular geometry (such as bifurcation, 
curvature of heart, twists, and bends) along with the pulsatile nature of blood flow could 
result in disturbed blood flow patterns such as flow separation, skewing and recirculation. 
2 
 
Figure 1. Percentage breakdown of deaths due to cardiovascular disease in the US 
(2008)
1
 
Disturbed flow leads to disturbed shear stress distribution, which plays a major role in 
atherosclerosis development. Once anchored, the atherosclerotic lesion further alters blood 
flow distribution, promoting the growth and propagation of the disease condition, by causing 
endothelial dysfunction, platelet activation and thrombus formation.  
 
 
 
 
 
 
 
In the coronary circulation, atherosclerotic plaques are most prevalent in the left 
coronary arteries (LCA), especially in the left anterior descending (LAD) branch near the left 
main (LM) bifurcation. Increasing evidence suggests the critical role of disturbed shear stress 
in the initiation and development of atherosclerotic plaques in coronary arteries. The 
complex blood flow patterns inside these arteries, arising due to the geometrical complexity, 
could induce highly disturbed shear stress. Endothelial cells (EC) present at the vessel wall 
and the platelets that are circulating in the blood flow are sensitive to these altered shear 
forces. The activation of these cells, along with their interactions, could affect the initiation 
and propagation of CHD and other related clinical conditions like thrombosis and stroke. 
3 
 
Thrombus formation (blood clot) inside the coronary circulation may completely block blood 
supply to cardiac muscles, resulting in cardiac ischemia (lack of oxygen). 
Computational fluid dynamics is an efficient tool to analyze blood flow inside 
complex vasculature and can help to estimate various hemodynamic parameters. A number 
of studies have been conducted in the past decades to analyze the coronary blood flow, but 
most models were geometrically simplified. The activation and response of both EC and 
platelets by shear stress have also been investigated in vitro by a number of researchers. One 
common drawback in many of these in vitro studies is the utilization of non-physiological 
shear stress conditions. Recently, the dependence of EC and platelet activation on both shear 
stress magnitude and exposure time has been established
2-4
. This underlines the importance 
of the use of physiologically relevant shear stress conditions.   
 The major goal of this study was to investigate the behavior of endothelial cells and 
platelets under physiologically relevant dynamic shear stress conditions. Computational fluid 
dynamics simulations were used to estimate dynamic shear stress conditions in normal and 
diseased coronary arteries. These shear stress waveforms were then applied to endothelial 
cells and platelets in vitro and their responses were measured. The results obtained from this 
study can significantly improve our understanding of the role of shear stress during the 
pathogenesis of CHD. 
 
 
 
 
4 
 
CHAPTER II 
 
 
SPECIFIC AIMS AND SIGNIFICANCE 
The major goal of this study was to investigate the role of physiologically relevant 
dynamic shear stress on the activation and function of vascular endothelial cells and 
circulating blood platelets, as well as their interactions.  
Global Hypothesis: Disturbed shear stress may activate endothelial cells and platelets, 
and promote their interactions, contributing to the pathogenesis of CHD and other related 
complications. This hypothesis was tested through the following specific aims. 
Specific Aim 1: To conduct numerical simulation of blood flow with platelets as a 
discrete phase, inside a human left coronary artery and to estimate the shear stress history 
on the vessel wall and platelets under normal and disease conditions.  
Specific Aim 2: To study the effect of physiologically relevant dynamic shear stress 
(obtained from numerical simulations from SA1) on vascular endothelial cells in vitro. 
Confluent endothelial cells were exposed to various pulsatile shear stress waveforms. 
Cell activation (ICAM-1 expression) and inflammatory response (tissue factor and 
thrombomodulin expression) were examined at both the protein level and RNA level.  
5 
 
Specific Aim 3: To investigate the effect of physiologically relevant dynamic shear stress 
on platelets. After dynamic shear stress treatment, platelet surface complement activation 
was measured. Changes in platelet proteome was also examined.  
Specific Aim 4: To examine the interaction between endothelial cells and platelets in 
vitro under physiological/pathological shear stress conditions. Vascular endothelial cells 
were exposed to dynamic shear stress in the presence of platelets. EC and platelet 
activation and associated inflammatory/thrombotic responses were examined.  
In this study, numerical simulation and in vitro experiments were combined to 
investigate the effects of dynamic shear stress on endothelial cells and platelets. Cell-cell 
interaction was investigated using a coupled-shearing system.  Results obtained from this 
study can help us to better understand the mechanisms of dynamic shear stress induced 
endothelial cell and platelet activation, which may help us to better characterize CHD and 
search for potential therapeutic solutions. 
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CHAPTER III 
 
 
BACKGROUND 
 
Atherosclerosis, a common vascular inflammatory disease condition, is 
characterized by the localization and growth of atherosclerotic lesions that results in the 
narrowing of blood vessels. This alters blood supply to the downstream region. 
Atherosclerosis is the leading cause behind most cardiovascular diseases, including 
coronary heart disease (CHD). Endothelial cells (EC) located in the innermost layer of 
blood vessels, are in direct contact with the flowing blood, and play critical roles in the 
pathogenesis of atherosclerosis.  
In our current level of understanding, the first step in initiation of atherosclerosis 
includes leukocyte sub-endothelial migration and deposition of lipids [especially low 
density lipoproteins (LDL)]
5;6
. This is facilitated by activation and/or damage of EC by  
biochemical or biomechanical stimuli or a combination of both. The resulting changes in 
EC permeability and surface adhesion molecule expression directly assist trans-
endothelial migration of  leukocytes.  
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3.1 Shear Stress 
Shear stress, the tangential friction force exerted by blood flow on adjacent fluid 
lamina and on the vessel wall, is one of the major contributors for the localization of 
atherosclerosis. Shear stress (τ) applied on any fluid element in a three dimensional space 
can be represented in tensor notation as shown in Equation 3.1. 
                        (
   
   
 
   
   
 
   
   
)        ……………(3.1) 
Where i, j, k = (x, y, z), v is velocity and µeff is the local effective viscosity.  
Under laminar flow conditions, the maximum shear stress at a particular cross 
section of a blood vessel is found at the vessel wall, and it decreases towards the center of 
the blood vessel. A typical velocity profile and shear stress distribution under laminar 
fully developed flow is presented in Figure 2. In the case of a continuous laminar flow, 
effective viscosity is the same as the dynamic viscosity. However, under turbulence 
conditions, effective viscosity is the sum of laminar and turbulent viscosity. Turbulent 
viscosity, which results from the local disturbances, depends on total turbulent energy 
and length/time scale.  
In general, shear stress at physiological levels helps to maintain the proper 
functioning of the endothelium and hemostasis, such as promoting anti-inflammatory and 
anti-thrombotic activities of the vessel wall
7;8
. Furthermore, platelet functions, including 
activation, adhesion and aggregation, are regulated by shear stress.  
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The pathogenesis of atherosclerosis is highly regulated by local blood flow and 
shear stress conditions. Atherosclerotic lesions are predominantly localized to a few 
major arterial beds, including coronary arteries, major branches of the aortic arch, the 
abdominal aorta, carotid arteries and iliac arteries
9
. The pulsatile nature of blood flow 
along with the complex anatomical geometry of these arteries (including twists, bends, 
curvature and bifurcations) produce regions of disturbed blood flow patterns. 
For instance, Figure 3 (taken from Chandran et al.) compares the flow patterns at 
a 60˚ (representing near symmetrical aorta-illiac) and a 90˚ (representing renal arterial 
branches) arterial bifurcation
10
. At the point of bifurcation, as the flow divides into the 
two daughter vessels, regions of flow separation and corresponding flow skewing are 
produced. In case of a symmetric bifurcation (Figure 3A), the majority of the flow is 
concentrated towards the bifurcation with secondary flow forming near the outer wall. 
For an asymmetric bifurcation (Figure 3B), the branch with a reduced flow has a large 
Figure 2. Velocity profile and shear stress distribution of a 2D fully developed 
laminar flow. 
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B 
flow separation zone and low- magnitude shear zone. Blood flow in the coronary arteries 
can be subject to both patterns, causing flow separation, recirculation, vortex and eddy 
formation
11
.   
 
 
 
 
 
 
 
 
A 
Figure 3. Flow distribution near an arterial bifurcation. (A) Representing a near 
symmetric aorto-iliac bifurcation, (B) Representing asymmetric (90˚) renal 
arterial bifurcation.
10
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Altered shear stress associated with these disturbed flow patterns may affect the 
functions of vascular wall endothelial cells and platelets greatly. Typically, low shear 
stress induces endothelial cell activation by altering the surface expression of adhesion 
molecules which play a key role in pathogenesis of atherosclerosis. In addition, platelets 
exposed to low magnitude shear stress for an extended duration have been shown to 
activate and aggregate
3;4;12
. Elevated shear stress may induce vessel wall damage
13
, 
platelet activation and thrombus formation
14
. Therefore, given the bipolar nature of shear 
stress, atheroprotective and atherogenic, it is important to understand the nature of shear 
stress (physiological or pathological) and its effects on various cellular functions 
pertaining to vascular disease conditions.   
3.2 Coronary Circulation 
Coronary arteries, originating from the base of the aorta, perform the critical 
function of supplying oxygen and nutrients to the cardiac muscles. The left coronary 
artery (LCA) supplies more than 50% of the heart muscles with blood
15
. The major 
branches of the LCA include the left main (LM), the left anterior descending (LAD) and 
the left circumflex (LCX) (shown in Figure 4) arteries. LCA has the highest probability 
for anchoring atherosclerosis. This is possibly due to the presence of LM bifurcation 
(which does not lie in a single plane)
16
 and the curvature of LAD (replicating the 
curvature of the heart)
17
, which may produce complex secondary flow
11
.   
The flow near the LM bifurcation is skewed towards the flow divider (inner wall), 
which creates a region of elevated wall shear stress at the point of bifurcation. In 
addition, near the entrance of LAD and LCX, flow separates, creating regions of varying 
11 
 
shear stress. Downstream (inside both LAD and LCX), the flow reattaches and re-
develops. Furthermore, if an atherosclerotic lesion grows inside LAD, it can gradually 
decrease the vessel diameter and introduce additional disturbances to the local blood 
flow, creating regions of high, low and oscillatory shear stress and recirculation flow. 
This emphasizes the importance of estimation of shear stress distribution inside the LCA 
under normal and disease conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Human heart showing coronary vasculature. Taken from Martini et al.
15
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3.2.1 CFD of coronary flow 
It is not possible to directly measure shear stress in vivo. Recently, non-invasive 
phase contrast magnetic resonance imaging (MRI) or pulsed ultrasound techniques have 
been used to measure the velocity gradient near the vessel wall, and from which shear 
stress can be calculated
18;19
. Carvalho et al. used a modified MRI technique to obtain wall 
shear rates in the carotid arteries
20
. The major drawback with this estimation is the 
assumption that the velocity profile is parabolic (fully developed), which is not true both 
spatially and temporally, and that the viscosity is constant. Such techniques are expensive 
and still need more validation. As an alternative, computational fluid dynamics (CFD) 
simulation of blood flow provides an efficient way to estimate shear distribution based on 
local blood flow conditions.  CFD can account for the complex vasculature, pulsatile 
nature of blood flow and non-Newtonian behavior of blood. The ability of CFD to 
provide accurate results with high spatial and temporal resolution has been well 
established. One of the major considerations in numerical estimation of shear stress is 
whether the computational model can closely mimic the in vivo physiological conditions. 
Other things that need be considered are flow assumptions and the computational 
capacity.    
Many studies have been conducted to analyze blood flow inside LCA using CFD 
and to estimate the magnitude and distribution of shear stress. The major limitation of 
many of these studies is the use of simplified arterial geometry. The simplification 
generally included the avoiding of changes in blood vessel diameter (taper), complex 
bends and the multi-planar curvature of the LM bifurcation, which could lead to 
inaccurate estimation in shear stress. In a study conducted by He et al., a simplified 3D 
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LCA model was used, and the time-averaged wall shear stress (WSS) was found to vary 
between 0.3 and 9.8Pa
16
. In a similar study by Perktold et al., a more realistic coronary 
artery model was employed and the average shear stress inside LM was found to be 
0.42Pa and that inside LAD was found to be 1.14Pa
21, very different from He’s study. 
As mentioned earlier, an atherosclerotic lesion (stenosis) can significantly alter 
the local blood flow conditions, and hence shear stress distribution. A study conducted by 
Varghese et al., using Ahmed’s stenosis model12, revealed an elevated shear stress  of 
120Pa before the stenosis throat and around 2Pa downstream of the stenosis
22
. Yao et al. 
compared the variation in shear stress distribution due to bend angle and stenosis 
severity. Their results indicated that the maximum WSS at stenosis throat in a curved 
vessel reached as high as 300Pa (with 60˚ and 120˚ bends, and 60% stenosis)23. In a 
similar study, Nosovitsky et al. investigated the effect of the presence of a stenosis inside 
a simple curved LCA model and revealed that the maximum WSS reached 125Pa at the 
stenosis throat
24
. The variation in shear stress magnitude estimated by these studies is due 
to their variation in the geometrical considerations and nature of blood flow assumptions 
(steady or unsteady).  
3.3 Endothelial cells and shear stress 
Endothelial cells (EC) are one of the most essential and functional component of 
blood vessels. Lying in the innermost layer, EC provide an interface between blood and 
the vessel wall. Under normal conditions, the integrative functions of vascular 
endothelium include: monitoring sub-endothelial migration of micro/macromolecules 
(vascular permeability), regulating the coagulation cascade (hemostasis/prevention of 
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excessive blood loss), maintaining vascular tone (production of vasomodulators) and 
promoting atheroprotective environment (secretion/expression of anti-atherogenic 
factors). EC have the ability to temporarily respond to intra/extra-vascular changes in the 
environment, such as localized inflammation, by changing their surface expression of 
adhesion molecules (E- and L- selectin, ICAM-1, VCAM-1) or releasing cytokines 
(TNF-α, IL-1)25. Most of the time, these changes occur during immune responses and are 
reversible. But under some pathological conditions, EC undergo an irreversible activation 
which plays a pivotal role in vascular disease initiation.  
EC are sensitive to blood flow induced shear stress.  Even though several studies  
reported that the lack of shear stress may induce EC apoptosis
26
, many studies have 
shown that shear stress is one of the agonists that can cause endothelial activation, injury 
and dysfunction. Through various mechanotransduction pathways, EC sense changes in 
shear stress.  In large- to medium-sized arteries, locations with laminar blood flow 
usually possess a pulsatile shear stress with net positive amplitude, varying between 0.1-
1Pa.  Around bifurcations or  downstream of a stenosis, low unidirectional pulsatile shear 
stress or oscillatory shear stress (bidirectional with the time-averaged shear stress 
approaching zero) can occur.  
Shear stress within the physiological range is generally regarded as 
atheroprotective while altered shear stress (either high or low) as atherogenic. 
Physiological shear stress preferentially induces EC elongation and the alignment of 
cytoskeletal components to the direction of blood flow
27
. This orientation helps to reduce 
the effective resistance and shear stress on EC. In a study conducted by Partridge et al., 
HUVECs were exposed to steady shear stress (1.2Pa for 16hr) and then treated with a 
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cytokine, TNF-α28. The nuclear factor κB (NF-κB, a major cytoprotective and 
proinflammatory transcription factor) activity was measured. Further NF-κB  also plays a 
major role in generation of ICAM-1. It was found that the pre-exposure to shear stress 
enhanced the NF-κB dependent cytoprotective transcription, while inhibiting the 
proinflammatory transcription.  On the other hand, EC do not undergo realignment under 
disturbed blood flow patterns, which could be attributed to the low magnitude of time-
averaged shear stress in a particular direction
29
. In addition to the structural change, 
disturbed shear stress is also known to activate EC and cause endothelial dysfunction. 
3.4 Shear stress induced endothelial cell activation in atherosclerosis 
The role of shear stress induced EC activation in the initiation and propagation of 
atherosclerosis is well established. Earlier studies relating shear stress to localization of 
atherosclerotic lesions resulted in two major opposing hypotheses. The high shear stress 
theory, proposed that the elevated shear stress would induce actual physical damage to 
the endothelium and expose the sub-endothelial layer to blood flow, leading to 
atherosclerosis initiation; and the low shear stress theory states that low shear stress 
activates the endothelium and leads to atherosclerotic lesion growth
10
.  
Shear stress induced EC activation responses, especially those pertaining to 
atherosclerosis, have been one of the major areas of research in the past couple of 
decades. One of the earliest studies on EC response to shear stress demonstrated that 
cellular damage would occur when exposed to elevated shear stress even for a short 
duration of time (37.9Pa for 60min)
13
. The results from this study formed the basis for 
high shear stress theory. However, a number of follow up studies confirmed the low shear 
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stress hypothesis
30
. Through clinical observation, Gibson et al. established a strong 
correlation between low magnitude wall shear stress and rate of atherosclerotic 
progression in human coronary arteries
31
. The major EC responses upon activation 
include loss of vascular integrity, enhanced surface adhesion molecule expression, EC 
surface phenotypical change from anti-thrombotic to prothrombotic, cytokine production 
and elevated immune responses
32
. Among all these responses,  increased 
expression/activation of adhesion molecules is of primary concern due to their role in 
leukocyte adhesion, leading to initial anchoring and growth of atherosclerotic lesions. 
Intercellular adhesion molecule - 1(ICAM-1) assists leukocyte trans-endothelial 
migration
32
. In addition, modulation in EC surface pro-/anti-thrombotic protein 
expression, including tissue factor (interacts with the coagulation cascade) and 
thrombomodulin (inhibits thrombin production), can lead to localized thrombus 
formation
33;34
. Further, changes in EC surface von Willebrand Factor (vWF) facilitates 
platelet adhesion and subsequent activation
35
. The expression and activation of all these 
EC proteins can be greatly affected by shear stress.  
3.4.1 ICAM-1 
ICAM-1 is a 95kDa transmembrane glycoprotein present on EC membrane, 
which assists in trans-endothelial migration of leukocytes
36
. Injured endothelium present 
near athero-prone sites express an increased amount of ICAM-1  compared to a healthy 
intact endothelium. In vivo coronary examination has also revealed an elevated ICAM-1 
expression near atherosclerotic lesions
37
. Elevated ICAM-1 expression was detected 
when EC were exposed to steady shear at 1Pa for 48hrs
38
. In a study conducted by Nagel 
et al., when exposed to low steady shear stress (0.3Pa) and varying shear stress (between 
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0.25Pa and 4.5Pa over 24hrs), EC expressed a similar ICAM-1 distribution, in a 
magnitude independent - time dependent manner
38
. Interestingly, when exposed to 
oscillatory shear stress (between +0.5 and -0.5Pa at a frequency of 1Hz), EC had a 11-
fold increase in ICAM-1 expression
39
. Morigi et al. found an elevated ICAM-1 
expression on HUVECs exposed to constant shear stress at 0.86Pa
40
. The functional 
significance of ICAM-1 increase was verified by an increase in leukocyte adhesion on 
EC exposed to laminar shear compared to static conditions. Furthermore, Tsuboi et al. 
detected a 1.27-fold increase in EC surface ICAM-1 expression (1.5Pa for 4 hrs) and the 
result was supported by an elevated expression of mRNA, quantified using real time PCR 
analysis
41
.  
 These in vitro studies suggest that EC exposed to physiological-level shear stress 
may have elevated ICAM-1 expression, which contravenes the in vivo observations that 
elevated ICAM-1 expression occurred at lesion prone sites characterized with disturbed 
blood flow patterns and altered shear stress
42
. This variation could be attributed to the 
shear stress used in the above studies (most of these studies used constant shear stress). 
Therefore, it is important to investigate ICAM-1 expression under physiologically 
relevant dynamic shear stress conditions.  
3.4.2 Tissue factor 
Tissue factor (TF) is a major inflammatory glycoprotein (47kDa), synthesized by 
EC and leukocytes. One important function of TF is its role in coagulation cascade 
through interactions with factor VIIa. When a vessel is injured, EC upregulate TF 
expression, which binds to coagulation factor VIIa (present in plasma) and catalyzes the 
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conversion of Factor X to Factor Xa
43
. The end product of coagulation cascade is the 
formation of fibrin which helps to prevent excessive blood loss. In order to prevent 
uncontrolled TF activity, EC also secrete tissue factor pathway inhibitor (TFPI).  In 
general, TFPI blocking studies have demonstrated that the modulation of TF 
expression/activity due to shear stress was primarily governed by the amount of TFPI 
released by EC
44
. Immunohistochemical observations of human atherosclerotic vessel 
sections have identified an over production of TF near the regions of plaque
45
, 
establishing its role in thrombotic complications during vascular inflammation.  
 In a study conducted by Houston et al., EC were exposed to constant shear stress 
at 1.5Pa, and the result showed a time-dependent increase in TF gene expression
46
. 
Grabowski et al. reported a down regulation of TF mRNA in EC, when they were 
exposed to constant shear stress at 0.068 and 1.32Pa
44
. Also, the binding of monocytes to 
cytokine-activated EC was found to induce TF generation (approximately 10-fold 
increase) in a time-dependent manner
47
. TF activity can be measured through its ability to 
convert Factor X to Factor Xa. Lin et al., observed a time-dependent increase in EC TF 
procoagulant activity (by both mRNA level and through Factor Xa formation) when EC 
were exposed to steady shear at 1.2Pa
48
. 
These studies reflect the ability of shear stress to modify TF expression on EC. 
Since most of the previous work has investigated EC response to constant shear, it is 
important to understand the role of physiological and pathological dynamic shear stress 
on TF expression and activity.  
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3.4.3 Thrombomodulin  
Thrombomodulin (TM), a cell surface glycoprotein, is predominantly produced 
and expressed by vascular endothelial cells. TM plays a critical role as a cofactor for 
thrombin, forming a 1:1 stoichiometric complex which serves as a catalyst for activation 
of protein C
49
. Protein C is a plasma glycoprotein. Thrombin activates Protein C into its 
activated form activated protein C (APC) which is amplified by the presence of TM (by 
>1000 fold). APC is an effective anti-coagulant which in the presence of protein S 
suppresses further thrombin generation by proteolytic inhibition of Factor Va and Factor 
VIIIa. The ability of TM to block thrombin was first proposed in a study conducted by 
Esmon et al., which established the physiological role of TM in inhibiting platelet 
activation
33
.  The antithrombotic effect of TM was substantiated in a study by Gomi et 
al., where the effect of recombinant human TM was tested both in vitro and in vivo
50
. 
Recombinant human TM produced in Chinese hamster ovary cells revealed a dose-
dependent increase in platelet clotting time (thrombin induced). Mice injected with both 
TM and thrombin (extracted from human) had a greater survival ratio when compared to 
those injected with only thrombin.  
One of the major atheroprotective responses of EC during endothelial dysfunction 
is the modulation of surface expression of TM. EC expression of TM can be greatly 
regulated by fluid shear stress. In a study by Malek et al., there was a 37% decrease in 
TM mRNA expression in bovine aortic endothelial cells (BAEC) when they were sheared 
at 1.5Pa. At the shear stress level of 3.6Pa, TM mRNA expression decreased further to 
about 16%
51
. Total protein expression measured by Western blot indicated that EC 
exposed to shear stress at 1.5Pa for 36hrs had a significant decrease (33%) in TM 
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expression. In a similar study conducted by Takada et al., human umbilical vein 
endothelial cells (HUVEC) were exposed to two different shear stress (low - 0.15Pa and 
high - 1.5Pa) and the TM expression was measured at both protein and mRNA levels
52
. 
EC had an increased surface TM expression as shear stress magnitude and shear exposure 
time increased, compared to that of control (measured by flow cytometry and ELISA). 
RT-PCR revealed an approximate 300% increase in TM mRNA levels. The contradicting 
results from both these studies could potentially be attributed to the variation in cell 
origin. However, these experiments have demonstrated that shear stress can modulate TM 
expression, at both protein and mRNA level. EC TM expression under physiologically 
relevant dynamic shear stress conditions is yet to be investigated.  
3.4.4 von Willebrand Factor 
Platelets interact directly with EC through von Willebrand factor (vWF). vWF is 
an ultrahigh molecular weight protein (more than 10,000kDa) synthesized by EC and 
stored in Weibel Pallade bodies (WPB)
53
. Activated EC have increased secretion of vWF, 
which leads to an increased local vWF concentration
54
.  The vWF subunit comprises of 
several domains, of which the A1 domain is the only binding site for platelet receptor, 
GPIbα. The binding of platelet GPIbα to vWF can trigger a series of platelet intracellular 
signaling pathways that contribute to platelet activation. Localized secretion of vWF was 
found to occur in areas of vascular inflammation and injury
55;56
.   
 A few recent studies have established the role of hemodynamic shear stress on the 
accessibility of the vWF binding site. Locally elevated shear forces were found to induce 
structural changes on vWF expressed on EC surface, aligning them with the shear 
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direction and increasing their adhesive nature. This shear-dependent structural change in 
vWF (at shear stress of 35±3.5 Pa) was verified by atomic force microscopy
57
. In flow 
fields with shear rates around 1000s
-1
, platelet adhesion to EC is greatly governed 
through surface immobilized vWF
58
. In addition to its role in shear induced platelet 
adhesion to vessel wall, the intracellular signal triggered by vWF-GPIbα binding plays a 
significant role in GPIIb/IIIa mediated platelet aggregation.  
 Given the role of vWF in initiating thrombogenic response, especially in the 
regions of pathological shear stress, it is essential to investigate how dynamic shear stress 
regulate EC vWF expression. Furthermore, the regions of vasculature with low pulsatile 
and oscillatory shear stress (for example, inside a recirculation zone) tend to have more 
platelet retention times than the other regions of vasculature. EC activation in these 
regions, specifically an increased expression in vWF, may promote platelet adhesion and 
subsequent aggregation.  
The literature review presented above reveals the importance of shear induced EC 
expression of ICAM-1, TF, TM and vWF and the discrepancies in our current 
understanding. In general, the alteration of these proteins at mRNA and protein levels has 
not been investigated under physiologically relevant dynamic shear stress conditions. The 
modulation of these proteins may have a significant role in pathogenesis of 
atherosclerosis and related complications. One of the major goals of this study was to 
investigate the activation of EC and their cellular responses to  physiologically relevant 
dynamic shear stresses.   
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3.5 Platelets 
3.5.1 Physiology and functions 
 Platelets are non-nucleated cells produced in the bone marrow. They circulate in 
the blood stream for about 7-10 days at a physiological concentration of 150,000-
500,000/µL. Platelets, as sub-cellular fragments released from megakaryocytes, are 
packaged with platelet specific granules (-granules and dense bodies) and cellular 
organelles.  Platelet α-granules contain a number of secretory proteins such as growth 
factors (platelet derived growth factors, PDGF), coagulation co-factor (factor V), 
angiogenic factors and adhesion molecules (P-selectin, vWF and thrombospondin). 
Platelet dense bodies contain a large amount of ADP, which can provide a positive 
feedback for platelet activation. The platelet plasma membrane is occupied by a number 
of transmembrane glycoproteins, including GPIb complex and GPIIb/IIIa, etc., which act 
as receptors and contribute greatly to platelet functions. Apart from the glycoproteins, the 
platelet membrane also contains phospholipids, especially phosphatidylserine (PS). 
Under resting conditions, PS is present on the inside of the plasma membrane and is not 
exposed to blood flow. When activated, PS is relocated to the outside of the cell 
membrane and facilitates coagulation.  
Platelets play a major role in hemostasis and thrombosis. Under physiological 
conditions, at the site of vascular injury, tissue factor (TF) expressed by the vascular wall 
endothelial cells interacts with Factor VIIa and forms TF-VIIa complex. The TF-VIIa 
complex triggers the coagulation cascade and leads to the formation of insoluble fibrin, 
which is the key component in a blood clot. The two important components for 
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coagulation that are provided by platelets include (1) negatively charged phospholipid 
membrane (PS translocated to outer surface) (2) coagulation factor V released from 
platelet α-granules. At the site of vessel injury, platelets adhere to the sub-endothelium 
through surface adhesion molecules. Upon initial adhesion, platelets also adhere to other 
activated platelets in the vicinity leading to thrombus formation.  
 Platelets can be activated by a number of agonists - both biochemical and 
biomechanical. Some of the important platelet agonists include ADP, thrombin, collagen 
(biochemical) and shear stress (biomechanical). The major platelet responses during 
activation include shape change, PS translocation and α-granule secretion. When 
activated, coagulant proteins stored in α-granules are released, this can lead to the 
activation of nearby quiescent platelets. Furthermore, thrombin generated as a byproduct 
of coagulation, is also a potent agonist for platelet activation.  
3.6 Platelets and shear stress 
3.6.1 Shear induced activation and aggregation  
Blood flow induced shear stress plays a major role in platelet activation, 
especially during the pathogenesis of thrombosis. It was found that altered shear stress 
could trigger platelet activation and aggregation. A number of investigators have 
examined the effects of shear stress on platelet activation in vitro. When exposed to shear 
stress of 5Pa, platelets secrete small amounts of ATP, ADP and serotonin
59
. Higher shear 
stress may lyse platelets. Anderson et al. reported platelet lysis at two different shear 
stress levels (16 and 60 Pa) after different durations of exposure
60
. In a recent study by 
Yin et al., platelet activation (based on prothrombinase activity and P-selectin expression) 
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was found to increase in a shear stress-dose dependent manner (increase in magnitude 
and duration)
3
. In addition to directly activating platelets, shear stress was found to act 
synergistically with other agonists (such as ADP, TRAP, epinephrine, etc.) and plasma 
cofactors to activate platelets
61
. 
 Besides activating platelets, shear stress also affects platelet aggregation. The 
current understanding of the mechanism behind shear stress-induced platelet aggregation 
is that at shear rates more than 1000s
-1
, platelets initially bind to the vessel wall or 
exposed extracellular matrix by the binding of platelet GPIbα to vWF62;63. This binding 
triggers an intracellular signaling pathway and activates platelets. Activation causes an 
increase in cytoplasmic Ca
2+
 concentration and the resulting ADP release triggers the 
binding of vWF/fibrinogen to GPIIb-IIIa which sustains platelet aggregation
64
. Despite 
the primary role of GPIIb/IIIa in platelet aggregation, blocking of vWF binding to GPIbα 
has been shown to result in inhibition of platelet aggregation
65
. Elevated shear stress 
could induce the binding of plasma soluble vWF to platelet surface receptor GPIIb/IIIa 
and to the GPIbα complex, and promote platelet aggregation. 
3.6.2 Shear exposure time 
 One of the major drawbacks of the above discussed studies is the usage of steady 
shear to induce platelet activation, which is not physiologically relevant. Shear-induced 
platelet activation depends on both the magnitude of shear stress and the duration of shear 
exposure. Platelets exposed to low shear stress for a long period of time, or exposed to 
high shear stress for a short time, can both be activated. Short duration exposure (30 sec) 
to elevated shear stress at 60Pa was found to induce platelet lysis, while a shear of 16Pa 
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for 5min was also found to induce a similar response
60
. Further, platelets exposed to a 
shear of 10Pa for less than 20sec were found to be minimally activated (based on P-
selectin expression) and reversibly aggregated (rapid disaggregation after the removal of 
shear stress)
66
. But when the duration was increased to longer than 20sec, platelets were 
highly activated and they irreversibly aggregated. In an attempt to investigate the platelet 
response near an arterial stenosis, Dong et al. exposed platelets to a complex pattern of 
elevated shear stress (10Pa) for a short duration (2.5sec) followed by a low shear 
exposure and found an enhanced platelet aggregation with minimal activation
66
.  In an 
attempt to understand the effect of exposure time, Hellums summarized the effects of 
both shear stress magnitude and shear exposure time on platelet activation (as shown in 
Figure 5)
67
, i.e., both high shear stress and low shear stress can activate platelets, with 
high shear stress requiring short time while low shear stress requiring long time.   
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Figure 5. Platelet activation, function of serotonin release, presented as a relation 
between shear stress and exposure time. This is a compilation of results from 
different researchers using different devices. Modified and redrawn from 
Hellums et al.
67
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3.7 Shear induced platelet - complement interaction 
 Activated platelets mediate and support a number of inflammatory processes 
inside the circulatory system. Platelets are acclaimed as the agents for focusing 
inflammatory response to certain regions of vasculature and promoting inflammation 
during vascular disease conditions. They are presented with a number of surface 
molecules, including P-selectin, integrins (αVβ3, α2β1, and αIIbβ3), CD40 ligand, CD40, 
and some junctional adhesion molecules
68
, which link them to the immune system. In 
addition to these immune reactions, platelets also support complement activation. 
3.7.1 Complement system 
 The complement system forms one of the major innate responses of the human 
immune system against the attack of any foreign bodies or pathogens. Complement is a 
complex biological system and consists of a group of serum proteases along with a set of 
regulatory proteins. The presence of foreign bodies or pathogens inside the human body 
will trigger complement activation and it plays a key role in clearing them from the 
system. The three major pathways of complement activation include the classical 
pathway, the alternative pathway and the lectin pathway (shown in Figure 6
69
). 
 Most of the components of the complement cascade are present in plasma and 
they circulate as zymogens. Under appropriate conditions, these zymogens become 
activated by proteolytic cleavage. The classical pathway is triggered by the binding of 
complement C1 complex (C1q-C1r-C1s) on the pathogen surface. This is followed by the 
cleavage of C4 and C2, leading to the assembly of C4b2b (known as C3 convertase). In 
the alternative pathway, low concentration of spontaneous activation of C3 happens in 
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C1 inhibitor 
CR1 
plasma which binds with factor B and cleaved by factor D, leading to the formation of 
C3bBb or C3 convertase. Following either the classical pathway or alternative pathway 
activation, C3 is cleaved into C3b and C3a by C3 convertase. C3b binds with C3 
convertase and forms the C5 convertase complex (C4b2b3b or C3bBb3b), which cleaves 
the successive components, finally resulting in the assembly of membrane attack complex 
(MAC) or C5b-9. The assembly of MAC on a cell surface will induce cell lysis, thereby 
the complement system clears pathogens from the human body.  
 
 
 
Figure 6. Complement cascade highlighting the classical, alternative and lectin 
pathway, resulting in the formation of membrane attack complex. Modified from 
Rutkowski et al.
69
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The effective regulation of the cytolytic potential of the complement system is 
carried out by a set of complement regulatory and inhibitory proteins. Some of the 
regulatory components include C1-inhibitor, C4b-binding protein, factor H, factor I, 
properdin, protectin and complement receptor 1. The two major inhibitory proteins that 
are involved in the classical pathway include C1-inhibitor (C1-INH) and the complement 
receptor 1 (CR1). C1-INH is present both in plasma and platelet α-granules. It can form 
covalent 1:1 complex with  both C1r and C1s and inhibit the formation of C1 complex, 
thereby inhibiting the complement cascade at the initiation phase. Meanwhile, CR1 can 
bind to both C3b and C4b and form opsonized immune complex
70
, which can be 
processed later by macrophages. Also, CR1 acts as a cofactor for factor I-mediated C3b 
cleavage
71
. Therefore CR1 functions as a regulator for both the classical and alternative 
pathway.  
 Complement activation has been found to play a major role in inflammation of 
various vascular disease conditions. The deposition of a number of complement proteins 
including C1q and C5b-9 have been found on atherosclerotic lesions
72-74
. Also, the 
plasma anaphylatoxins C3a, C4a and C5a that are released during the propagation of 
complement cascade can potentially alter the vascular permeability. In addition, 
atherosclerotic lesions, especially human coronary plaques, have revealed an increased 
level of C3a and C5a receptors
75
. 
3.7.2 Platelet complement activation 
 Recently, activated platelets were found to support complement activation to 
completion. Both classical and alternative pathway complement activation is supported 
30 
 
by platelets
76
. Platelets activated by elevated shear stress were found to induce classical 
pathway complement activation, by increasing C1q and C4d deposition on their surface
3
. 
In addition to the classical pathway, platelets were also found to support alternative 
pathway complement activation. P-selectin, a platelet activation marker protein, was 
found to facilitate the deposition and activation of C3, which could trigger the alternative 
pathway complement activation.  
 Furthermore, thrombin, which is a potent platelet agonist, also acts as a C5-
convertase. Thrombin can biologically activate C5 even in the absence of C3 
convertase
77
. On the other hand, the assembly of C5b-9 on platelet surface was found to 
induce platelet activation and subsequent secretion of procoagulant proteins
78;79
. These 
studies reveal the intrinsic ability of platelets to cross communicate with complement 
proteins. But the effect of dynamic shear stress on the interaction between platelets and 
complement cascade is yet to be investigated. 
3.8 Platelet Proteomics 
               Proteomics can provide an efficient way for comprehensive analysis of protein 
expression under particular stimulation. Platelet proteomics follows two general 
approaches including global cataloging of all the proteins present in platelets and the 
functional characterization of subproteomes or changes within a proteome in response to 
a particular stimulation. In a recent study by Yin et al., platelet proteomic profiles in 
response to various agonists were analyzed using surface-enhanced laser 
desorption/ionization (SELDI) time of flight (TOF)
80
 mass spectrometry. Distinct spectral 
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patterns were detected between resting and activated platelets in the low-molecular 
weight range (2-20 kda).  
 SELDI-TOF is a variation of conventional matrix assisted laser desorption 
ionization - time of flight (MALDI-TOF) mass spectrometry (MS), which enables a high 
throughout generation of protein profiles.  
A SELDI protein chip array contains multiple spots composed of specific 
chromatographic configurations (cation/anion/hydrophobic/metal affinity). When a 
particular sample is applied to the chip, proteins/peptides in the sample are captured to 
this surface by electrostatic interaction, affinity chromatography or adsorption. After 
applying a suitable energy absorption matrix on the substrate, the captured proteins that 
are co-crystallized with the matrix are ionized using a nitrogen laser and a spectral profile 
is created by measuring TOF.  The basic schematic of the SELDI system is shown below 
in Figure 7
81
. 
 
 
 
 
 
 
 
 
 
Figure 7. Functional schematic of the SELDI system showing protein chip, 
laser ionization and TOF measurement. Modified from Issaq et al.
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Proteomics technique can improve our understanding of platelet behavior at the 
post-translational protein level. Furthermore, this method can be used to analyze the 
variation in proteome and map various signaling cascades involved in different platelet 
functions. In this study, SELDI MS was used to investigate the effects of dynamic shear 
stress (at physiological and pathological level) on platelet proteomic patterns.  Results 
obtained here can potentially lead to the identification of disease specific biomarkers for 
development of novel diagnostic procedures and interventional therapeutics. 
3.9 Endothelial cell – Platelet interaction 
EC and platelets interact in many ways. EC can express proteins (like TF, vWF) 
to attract platelets to the blood vessel wall. Under physiological conditions, this adhesion 
leads to platelet aggregation and clot formation to stop bleeding. Under disease 
conditions, platelet adhesion may induce thrombus formation.  
EC and platelets can interact directly through their corresponding surface ligands 
and receptors. Activated platelets have elevated P-selectin expression on their surface, 
which mediates platelet rolling on activated EC
82, while elevated GPIbα expression 
enhances platelet interaction  with EC surface vWF to enable platelet adhesion
58
. Both in 
vitro and in vivo studies have verified elevated adhesion of activated platelets to EC
83;84
. 
EC and platelets also interact through certain chemical messengers and proteins secreted 
upon activation. For instance, chemokines (such as TNF-α) released by activated EC are 
known to induce platelet microparticle generation
85
. With the advent of proteomics, 
platelet specific proteins were found localized to atherosclerotic plaques
86
. Activated 
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platelets are known to induce inflammation in EC, evidenced by elevated ICAM-1 and 
monocyte chemoattractant protein (MCP-1) expression
87;88
. 
Very few studies have investigated the direct interaction between EC and 
platelets, especially under shear stress conditions. P-selectin, expressed on activated 
platelet surface, is known to induce tethering and rolling of platelets on endothelium 
through its ligand PSGL-1, especially under low shear
82
. Also, an in vivo study with P-
selectin double knock out (apoE-/- CD62P-/-) revealed a reduced atherosclerotic plaque 
occurrence compared to a normal mice
89
. In another in vitro study conducted by Macey et 
al., platelet microparticle formation was found to increase in whole blood flowing on 
TNF-α activated EC compared to flow on non-activated EC or after static co-culture85. 
Also, some in vivo studies have presented that platelets roll and adhere firmly to 
microvascular endothelium during postischemic reperfusion
84
. In addition to these direct 
interactions, platelets are responsible for a number of inflammatory response on ECs, 
especially on focusing responses to a particular vascular location under flow
90
.  
Based on the literature presented above, it is evident that the interaction between 
endothelial cells and platelets could be affected by flow. As a consequence, the altered 
interaction could affect the flow induced activation/response of EC and platelets 
individually. However, there is a gap in literature investigating EC-platelet interaction 
under physiologically relevant flow conditions. By filling this gap, our studies will help 
better characterize how EC-platelet communication/interaction affect cardiovascular 
disease progression.  
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The literature review above demonstrates that dynamic flow conditions and cell-
cell interactions play very important roles in platelet and EC activities and disease 
development.  The major focus of this project was to apply physiologically relevant 
dynamic shear stress to both endothelial cells and platelets and study their behavior. Also, 
their interactions were investigated in a EC-Platelet coupled shearing system. The results 
from this study will enable us to understand the interaction between EC, platelets and 
dynamic shear stress, especially during CHD initiation and development. 
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CHAPTER IV 
 
 
MATERIALS AND METHODS 
 
 
4.1 Numerical Modeling  
4.1.1 LCA model 
A physiologically realistic 3D human left coronary artery (LCA) model was 
developed using the computer aided design (CAD) software Pro-E Wildfire 4.0 (PTC). 
The LCA model was constructed based on the dimensions and geometrical information 
obtained through an anatomical study conducted by Dodge et al.
91;92
. In this study, the 
intrathoracic spatial locations of specific coronary artery segments were measured (on a 
normal human heart) through angiographic imaging. Dodge et al. presented an accurate 
measurement of both the spherical coordinates of centerline trajectory (left main - LM, 
left anterior descending artery - LAD, left circumflex artery -LCX and their branches) 
and the vessel diameters at different cross sections along the trajectory. This provided a 
way to build a physiologically realistic coronary artery model including the bifurcation, 
tapering and myocardial curvature. 
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The centerline trajectory of the LCA was first constructed using the spherical 
coordinates. Using various cross sectional diameters, the artery model was extruded 
through the trajectory. The branches in the model included LM, LAD, LCX, septals and 
diagonals. For this study, the 3D LCA model (presented in Figure 8) was constructed 
under both normal and disease conditions, which were modeled by adding a stenosis 
(30%, 60% and 80% reduction in vessel diameter) in the LAD branch downstream of the 
bifurcation (8mm from the apex of bifurcation). The key geometrical parameters 
including the vessel diameters, length of different branches and bifurcation angle are 
presented in Table 1. 
 
 
 
 
 
 
 
 
 
 
37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Left main  
Left circumflex 
Left anterior 
descending 
Diagonals 
Septals 
A 
B 
C 
D 
Figure 8. Physiologically realistic 3D computational model of the human left 
coronary artery used in this study. (A-D) represents LAD branch under normal, 
30%, 60% and 80% stenosis condition respectively. 
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Parameter Value (mm)
Inlet Diameter 4.5
Length 11
Inlet Diameter 3.8
Length 118
Outlet Diameter 1.9
Inlet Diameter 3.7
Length 76.8
Outlet Diameter 1.7
74.83˚Bifurcation Angle
LM
LAD
LCX
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Key geometrical parameters used for construction of human LCA 
model used in this study 
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4.1.2 Computational Fluid Dynamics 
Fluid flow in general is governed by three fundamental principles - conservation 
of mass, conservation of momentum and conservation of energy. The general equation 
for incompressible Newtonian fluid motion includes the continuity equation (mass 
balance – Equation 4.1) and the Navier-Stokes equation (momentum balance – Equation 
4.2): 
      ………………………………………..……..….(4.1) 
        (   )   ……………………………….(4.2) 
Where U is velocity vector [U ≡ (u, v, w)], P is pressure, ρ is fluid density and µ is 
dynamic viscosity of the fluid. In this case, a constant density of 1.06g/mL was used to 
model blood, while the local effective viscosity estimated by the solver was used to 
determine shear stress.  
Computational fluid dynamics (CFD) provided a suitable way to qualitatively 
analyze the blood flow. In general, the fluid domain was subdivided into small elements 
(discretization) and the general equations were iteratively solved for each element 
(numerical solutions). For each time step, each node was updated (locally) with a new set 
of values.  The accuracy of solution was dependent on the convergence of a set of 
predetermined variables, usually momentum and continuity variables. Based on the 
maximum Reynolds number (Re) in the domain (directly proportional to fluid velocity 
and cross sectional diameter shown in Equation 4.3), the type of flow (laminar / 
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turbulent) was determined (laminar flow if Re < 2300, transition to turbulent flow if Re > 
2300) and suitable solvers were utilized (modified Navier-Stokes equations) accordingly.  
   
   
 
 ………………………………………….. (4.3) 
where ρ is fluid density, V is the fluid velocity, D is the length scale (cross sectional 
diameter for a circular cross section) and µ is dynamic viscosity of the fluid.  
In the case of non-circular cross sections, Reynolds number (Reij) was calculated 
for each mesh element using the fluid velocity (Vi,j) and the length scale of that particular 
element (ΔXij), as shown in Equation 4.4. 
     
        
 
 ……………………………………….. (4.4) 
In this study, the Reynolds number indicated that the flow was well within the 
laminar regime for normal, 30% and 60% stenosis conditions; hence a laminar solver was 
used. However, as complex flow patterns emerged under the 80% stenosis condition, a 
low Reynolds number k-ω turbulent solver was used.  
4.1.3 Meshing 
The LCA model (Figure 12) was meshed using a computational meshing package 
ICEM CFD v13.0, a preprocessor program for CFD solvers. A hybrid meshing scheme 
involving a combination of both hexahedral and tetrahedral elements was used to 
discretize the model. Particular regions of interest (bifurcation and stenosis region) were 
finely meshed compared to the rest of the model in order to optimize the memory loads 
and computing capacity while providing a feasible spatial resolution. All the results from 
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this study were tested for mesh independence. The total number of discretized elements 
for each model is listed in Table 2. 
 
 
 
 
 
4.1.4 Coronary blood flow analysis 
Solvers 
The 3D human LCA CAD model (normal, 30%, 60% and 80% stenosis), 
constructed using Pro-E (WF 4.0, PTC) and discretized in ICEM CFD (ANSYS, v13.0) 
was imported into CFX-Pre (ANSYS v13.0), where the physical parameters of the model 
was configured. The flow was assumed to be laminar under normal, 30% and 60% 
stenosis conditions, while a k-ω turbulent solver was used to solve the flow field under 
the 80% stenosis condition. After defining all necessary assumptions and boundary 
conditions (given below) the model was exported to the CFX solver. Upon convergence 
Condition No. of nodes No. of elements 
Element size range 
(mm) 
Normal 209,520 961,733 0.014 – 0.432 
30% stenosis 184,277 857,582 0.006 – 0.471 
60% stenosis 168,182 761,719 0.072 – 0.536 
80% stenosis 233,049 1,062,421 0.063 – 0.473 
Table 2. Total number of nodes and elements under each condition that were 
used in this study. 
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of momentum and continuity, the results were exported and analyzed using the CFD post 
package.   
Assumptions  
The coronary blood flow was solved using the following assumptions: 
 Fluid medium: Blood was modeled as a continuous phase fluid with density of 
1.06 g/cc. 
 Fluid inlet: A transient coronary inlet velocity waveform was used (Figure 9)93, 
and a fully developed parabolic inlet velocity profile (Figure 10) was defined at 
the inlet. 
 Walls: The vessel wall was assumed to be rigid and non-porous, neglecting the 
viscoelastic property of the blood vessels. 
 Transient flow: All simulations were conducted for a total of 3 cardiac cycles 
(0.9sec per cardiac cycle) with a time step size of 0.1 sec. 
 Convergence: The convergence criteria for velocity components and continuity 
variables were set at 1.00E-6, while that of turbulence variables (k and ω) was set 
at 1.00E-3. A minimum of 600 iterations was required for each time step to reach 
convergence.  
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Figure 9. Inlet velocity waveform used in CFD simulations. Based on coronary 
input velocity for 3 cardiac cycles. 
Figure 10. 3D fully developed velocity profile at the entrance of left main branch 
(t=0.8sec).  
Fully developed parabolic 
velocity profile at the LM inlet 
Flow Direction 
Time (t) = 0.8 sec 
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Boundary conditions 
The discretized LCA model was exported to the CFX Pre software (pre-
processing tool in the ANSYS CFX v13.0 package) and the following boundary 
conditions were defined. 
 Inlet: The inlet surface boundary was defined as a velocity inlet (Figures 9 and 10). 
The maximum inlet velocity varied between 0.009 (at t = 0.7sec) and 30 cm/sec (at t 
= 0.9sec), at a normal heart rate of 72bpm.  
 Outlet: The outlet surface was modeled as a pressure outlet and was set at 
atmospheric pressure. The distance of the outlet surface was sufficiently far away 
from regions of interest including the bifurcation and the stenosis (i.e., at least 9 times 
the inlet tube diameter from the bifurcation), hence the boundary condition should 
have negligible effect on the flow pattern.  
 Walls: The rigid non-porous vessel wall boundary was defined as no-slip condition.  
Shear stress history 
After the simulation ended, shear stress at a particular wall node inside regions of 
interest (like stenosis throat, recirculation zone) was estimated in the solver (based on 
Equation 3.1). Shear stress history was constructed as shear stress at a particular node at 
every time step during one cardiac cycle. The computed shear stress history was then 
exported to a shearing device for the following in vitro studies.  
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4.1.5 Platelet Modeling  
 Platelets were modeled as a discrete phase and platelet trajectories as they 
traveled through the LCA were estimated using the Euler-Lagrangian approach. Platelets 
were seeded inside the LCA (released at LM inlet) at a rate of 1000 platelets per cardiac 
cycle and the simulations were conducted for at least 3 cardiac cycles. At the end of 
simulation, trajectories of platelets as they passed through the LAD branch of LCA, 
under normal and disease conditions, were calculated using the Lagrangian formulation 
in CFX (ANSYS, v13.0). The trajectories were calculated by integrating the particle 
force balance equation as shown in Equation 4.5.  
   
 
  
   (     
 
)  
  (    )
  
 
  
  
 ……………….. (4.5) 
Where FD is drag force, (     
 )  is particle relative velocity, and Fi accounts for 
additional forces like pressure gradient, Brownian motion and Saffman lift. At every time 
step, after iteratively solving the particle location, the shear stress value for that particular 
location (mesh element) was computed by the solver (based on Equation 3.1). By plotting 
the change in shear stress magnitude for every time step (along their trajectory), the shear 
stress history of platelets inside LCA was calculated.  
Assumptions  
 Platelets: Platelets were modeled as solid particles with a diameter of 4 µm, density 
of 1.2g/ml and viscosity of 1.2cP. A shape factor of 0.2 was defined to account for the 
flattened shape of platelets.  
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 Seeding density: 1000 platelets per cardiac cycle were released at the left main inlet 
surface and it was assumed that the initial velocity and acceleration (at time t=0) of 
platelet-like particles was 0. 
 Reactivity: Platelet-like particles were chemically and biologically inert.   
Two-way coupling: A two-way coupling scheme was employed, where the fluid phase 
influenced the drag and turbulence of particulate phase, and the particulate phase 
influenced the source terms (mass, momentum and energy) of the continuous phase. 
 
4.2 Detailed methods section 
Platelets: Fresh platelet rich plasma (PRP), anti-coagulated with 0.32% sodium citrate, 
was purchased from Oklahoma Blood Institute (Oklahoma City, OK) and platelets were 
separated from plasma by centrifugation (3000 rpm for 9 min). Washed platelets were 
prepared by resuspension of platelet pellets in HEPES (hydroxyethyl piperazine 
ethanesulfonic acid) buffered modified Tyrode's solution (HBMT: 0.137M sodium 
chloride, 2.7mM potassium chloride, 0.36mM monobasic sodium phosphate, 12mM 
sodium bicarbonate, 2mM magnesium chloride, 0.2% BSA, 5.5mM dextrose and 0.01M 
HEPES, pH to 7.4). The final platelet concentration was adjusted to 250,000/µl for all 
experiments. Platelet poor plasma (PPP), collected as supernatant after centrifugation of 
PRP, were aliquoted and stored at -80˚C until use. 
Cell Culture: Human coronary artery endothelial cells (HCAEC) were purchased from 
Lonza (Walkersville, MD) and used between passages 2 and 8. HCAECs were grown to 
confluence on 6-well plates or petri dishes (6 cm) according to experiment requirements. 
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The cells were maintained in endothelial cell basal medium, supplemented with growth 
factors, including 2% fetal bovine serum (FBS), 0.1% hydrocortisone, hFGF, VEGF, R3-
IGF-1, ascorbic acid, hEGF, GA-1000 and heparin (Lonza, Walkersville, MD).   
Shearing Device: Dynamic shear stress waveforms estimated from numerical 
simulations were applied to endothelial cells and platelets using two shearing devices: a 
cone and plate shearing device and a parallel-plate flow chamber.  
Cone-Plate Shearing Device: A modified cone and plate viscometer, customer-built to 
accommodate 6-well plates (shown in Figure 11A), was used to apply various shear stress 
to platelets and endothelial cells
3;94;95
. The cones were made of ultra-high molecular 
weight polyethylene (UHMWPE), attached to the bottom of 4 stepper motors which were 
controlled by a PC. By adjusting the speed of the cones, shear stress generated in the 
wells could be precisely controlled. The cone-plate device used in this study had a cone 
angle of 0.5˚ and a radius of 1.733cm. This shearing device was primarily used to shear 
endothelial cells (EC) since they were usually cultured in 6-well plates. To apply shear 
stress to platelets, a cone-and plate system with a single cone was often used (Figure 11B, 
cone angle: 2˚ and radius: 2.455cm).  
A uniform shear stress profile was generated in these devices, and it was directly 
proportional to the angular velocity of the cone. A schematic cross sectional view of the 
cone-plate device depicting the flow domain is shown in Figure 12.  
The modified Reynolds number of the cone and plate shearing system can be calculated 
using Equation 4.7. The flow was laminar when  ̃   . 
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                            ̃  
     
   
…………………………………….. (4.7) 
Where r is the radius of the cone and ν is the kinematic viscosity (=µ/). 
Under laminar conditions, shear stress generated by the cone-plate device can be 
calculated by Equation 4.6. 
  
  
 
…………………………………….…..(4.6) 
Where μ is dynamic viscosity of the fluid, ω is the angular velocity of the cone and α is 
the cone angle. While remaining in the laminar regime, the 6-well plate shearing device 
used in this study was capable of generating a maximum shear stress of 12Pa and the 
single cone shearing device was capable of generating a maximum shear stress of 7.2Pa.  
 
 
 
 
 
 
 
Figure 11. Modified cone and plate hemodynamic cell shearing device. Assembly 
of cones with the microstepper motor in a (A) 6-well plate used to shear EC and 
(B) single cone plate system used to shear platelets. 
B A 
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Shear stress history, estimated from the CFD simulation, was programmed into 
this cone and plate system to mimic the physiologically relevant dynamic shear stress 
conditions in vitro on a monolayer of EC or platelets. All experiments were conducted at 
37˚C. For some experiments, platelets and EC were exposed to shear stress 
simultaneously, which was referred to as the coupled shearing experiments.   
 
 
Parallel Plate Flow Chamber: A parallel-plate perfusion chamber was used alternatively 
to apply shear stress simultaneously to platelets and EC.  The flow chamber was made of 
transparent polyvinyl chloride (channel height – 1mm, Figure 13A). The inlet and outlet 
of the chamber were connected to a peristaltic pump through tygon tubing, forming a 
flow loop (Figure 13B).  The maximum shear stress generated in this chamber is 
calculated based on Equation 4.8 as given below.  
  
   
   
………………………………….… (4.8) 
Where μ is the fluid viscosity, b is the width of the chamber, h is the height of the 
chamber and Q is the flow rate inside the chamber. By adjusting the flow rate of the 
Figure 12. Cross sectional view of the cone-plate device used in this study to apply 
shear stress to endothelial cells (cultured on the bottom stationary plate) and 
platelets suspended in the flow domain. The device applies constant shear to both 
the cells attached on the bottom and also to the cells that are in suspension.  
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pump, shear stress generated in the flow chamber can be precisely controlled. The flow 
chamber used in this study can generate shear stress ranging from 0.01 to 4.5Pa (by 
adjusting the flow rate up to a maximum of 660mL/min). Endothelial cells were grown to 
confluence on a glass coverslip (Electron Microscopy Sciences, Hatfield, PA), which was 
then placed on the bottom of the flow chamber. In the coupled shearing experiments, 
washed platelets were perfused through the chamber. The chamber was designed with 
sufficient entrance length such that the flow was fully developed as it reached EC on the 
cover slip, placed in the middle of the chamber. A schematic representation of the flow 
field is given in Figure 13C.  
EC placed on the bottom of the chamber were exposed to a uniform shear stress 
(Equation 4.8), while platelets that were suspended in the flow field experienced a wide 
range of shear stress. For instance, in the region where flow was fully developed, 
platelets that were traveling close to the top and bottom wall experienced higher shear 
stress, compared to those travelling towards the center of the flow (as discussed in 
Section 3.1). This is a more physiologically relevant setup for EC-platelet interaction 
studies. However, due to the complex shear stress distribution on platelets, results 
obtained from these experiments, especially the platelet responses could be hard to 
interpret. 
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A A B 
C 
Figure 13. (A) Parallel plate flow chamber for shearing EC and platelets. (B) 
Complete flow loop set up with the chamber. (C) Schematic view of the flow 
development in the parallel plate flow chamber. 
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4.3 Effect of dynamic shear stress on EC 
The wall shear stress estimated from numerical simulations was applied to EC in 
a cone and plate shearing device. The dynamic shear stress waveforms that were used in 
this study included normal, low-magnitude unidirectional, low oscillatory and high-
magnitude pulsatile shear stress.  Figure 14 depicts all four waveforms along with their 
corresponding locations. Normal shear represents the pulsatile shear stress history on a 
normal LCA wall (varies between 0.1 and 1 Pa), low magnitude unidirectional shear 
represents that inside the recirculation zone downstream of the stenosis (0.01 to 0.4 Pa), 
and high-magnitude pulsatile shear represents shear stress history on LCA wall at the 
stenosis throat (between 0.1 and 6 Pa, for 60% disease severity). The low oscillatory 
shear replicates shear history at certain regions near the bifurcation or in the recirculation 
zones where bidirectional flow occurs (±0.3 Pa, no net forward component). To measure 
changes in EC surface proteins and at mRNA level, EC were sheared for 60 min at 37C. 
To measure changes in total proteins, EC were sheared for 120 min so as to ensure that 
the shear exposure time was long enough to induce changes in total protein expression, if 
any.  
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Figure 14. Shear stress history on EC vessel wall (over 3 cardiac cycles) inside 
LAD during CHD. (C) Normal waveform corresponds to WSS inside normal 
healthy LAD as shown in (A). (D) High magnitude pulsatile shear corresponds to 
WSS at 60% stenosis throat shown in B. (E, F) Low magnitude unidirectional 
and bidirectional shear waveform corresponding to WSS on EC present inside 
recirculation and oscillatory zone as shown in B. (oscillatory - bidirectional 
pulsatile shear with no net forward component) 
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4.3.1 Materials used 
Antibodies: Mouse monoclonal anti-human ICAM-1 (1μg/mL, Ancell Corporation, 
Bayport, MN), tissue factor (1μg/mL, Abcam, Cambridge, MA), thrombomodulin 
(1μg/mL, Abcam) and von Willebrand Factor (1μg/mL, Abcam) antibodies were used to 
measure EC ICAM-1, TF, TM and vWF expression. For ELISA, primary antibody 
binding was detected using an alkaline phosphatase conjugated goat anti-mouse 
secondary antibody (1:1000 in PBS, Sigma Aldrich); for Western blot, primary antibody 
binding was detected using a horseradish peroxidase (HRP)-conjugated goat anti-mouse 
secondary antibody (1:1000 in PBS, Abcam). To detect total vWF expression in EC using 
Western blot, rabbit polyclonal anti-human vWF primary antibody (1μg/mL, Abcam) was 
used along with a HRP conjugated goat anti-rabbit secondary antibody (1μg/mL, 
Abcam).    
Buffers: 
 Phosphate-Buffered Saline (PBS) 
PBS contains 9% NaCl, 1M sodium phosphate dibasic, 0.5M sodium phosphate 
monobasic. The pH was adjusted to 7.4 using 1 M HCL. 
 Tris-Buffered Saline (TBS) 
TBS was made with 19.97mM Tris and 0.15M of NaCl and set to the pH of 7.4. 
 0.5% Glutaraldehyde (Sigma Aldrich) 
 100mM Glycine – 0.1% BSA 
 Lysis Buffer 
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0.1% Triton X – 100 (in PBS) containing proteolytic inhibitors aprotinin (1μg/mL), 
leupeptin (1μg/mL) and phenylmethylsulfonyl fluoride (PMSF, 1mM).   
4.3.2 Shear stress induced EC activation – ICAM-1 expression 
4.3.2.1 Surface protein expression measurement using a solid phase ELISA approach 
EC exposed to different pulsatile shear stress waveforms (60min, 37°C) were 
examined for activation by measuring EC surface ICAM-1 expression using a solid phase 
ELISA approach. After shearing, cells were washed in PBS (2X) and fixed using 0.5% 
glutaraldehyde (15min, 37°C), followed by neutralization with 100mM Glycine – 0.1% 
BSA for 30 minutes. EC surface ICAM-1 expression was measured using a murine 
monoclonal anti-human ICAM-1 antibody (60min, 37˚C). After washing with PBS (2X), 
primary antibody binding was detected using alkaline phosphatase conjugated goat anti-
mouse secondary antibody (60min, 37°C). After washing (2X), secondary antibody 
binding was detected using p-nitrophenyl phosphate substrate (pNPP, 1mg/mL) (Pierce 
biotechnology, Inc.) and color development was quantified by absorbance at 405nm in a 
microplate reader. For all experiments, untreated endothelial cells (EC maintained under 
static conditions) were used as control. EC incubated in PBS without primary antibody 
was assayed for non-specific antibody binding.  
4.3.2.2 Total protein expression using Western blot 
In addition to surface ICAM-1 expression, shear-induced changes in EC total 
ICAM-1 expression was measured using Western blot. For Western blot experiments, EC 
were sheared for a duration of 120min (37°C) to ensure shear exposure was long enough 
to affect total protein expression. After being exposed to different pulsatile shear stress 
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waveforms, EC were trypsinized and collected by centrifugation (3000rpm, 6min). The 
endothelial cell pellet was resuspended and incubated in lysis buffer (0.1% Triton X-100 
in PBS) supplemented with proteolytic inhibitors including aprotinin (1μg/mL), leupeptin 
(1μg/mL) and PMSF (1mM) (at 4˚C, 60min) (volume normalized to cell count after 
shearing). Samples were then centrifuged at 14,000 rpm for 5min, and the supernatant 
containing cytosolic proteins was collected and stored at -80˚C until use. Gel 
electrophoresis was conducted on a 10% polyacrylamide gel, at 150V and 80mA 
(approx.) for 100 minutes.  The protein bands were then transferred to a nitrocellulose 
membrane (0.2μm pore size, Whatman, Dassel, Germany) for Western blot analysis, 
using a mouse monoclonal ICAM-1 antibody (60min at RT). Primary antibody binding 
was detected using a HRP-conjugated goat anti-mouse secondary antibody. Secondary 
antibody binding was detected using a HRP chemiluminescent substrate (ECL, Thermo 
Fisher Scientific Inc., Rockford, IL) and read in a chemiluminescent imaging device 
(FluorChem HD2 system, Cell Biosciences, Santa Clara, CA). The intensity of protein 
bands was quantified using spot densitometry analysis (AlphaView software, Cell 
Biosciences). β-actin expression was used as loading control. 
4.3.2.3 ICAM-1 mRNA expression  
Shear stress induced changes in ICAM-1 expression at mRNA level was measured 
using RT-PCR. After exposure to shear stress (60min, 37˚C), the cells were collected in 
TriZol (Invitrogen) and the total RNA was isolated. RNA samples were then reverse 
transcribed using the cDNA synthesis kit from Quanta Biosciences (Gaithersburg, MD), 
following the manufacturers protocol. The forward and reverse primers for ICAM-1 were 
designed using Primer Express Software (Applied Biosystems, Inc., Foster City, CA). 
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The forward primer for ICAM-1 was 5' -AGACAGTGACCATCTACAGCTTTCC -3', 
and the reverse primer was 5' - CACCTCGGTCCCTTCTGAGA -3'. β-actin was used as 
endogenous control. The forward and reverse primer sequence for actin were 5' - 
TGCCGACAGGATGCAGAAG -3', and 5'- CTCAGGAGGAGCAATGATCTTGAT-3' 
respectively. For amplification of ICAM-1 expression, 2µl of cDNA was added to 
SYBR® Green PCR master mix (Applied Biosystems) containing 0.25µM forward as 
well as reverse primers. PCR was performed in a Step-One-Plus system (Applied 
Biosystems). Relative mRNA expression (RQ) normalized to control EC (cells that were 
not exposed to shear stress) was calculated using the Ct method.   
4.3.3 Shear stress induced EC injury – Tissue factor (TF) and Thrombomodulin 
(TM) expression 
4.3.3.1 Surface protein expression using ELISA 
After shear exposure, EC surface tissue factor and thrombomodulin expression 
was measured using monoclonal murine anti-human tissue factor and thrombomodulin 
antibodies, using a solid phase ELISA approach as described before.   
4.3.3.2 Total protein expression using Western blot 
Similarly, total tissue factor and thrombomodulin expression in EC was measured 
using Western blot as described previously. Alternatively, total tissue factor expression in 
EC was measured using a commercial sandwich ELISA kit (American Diagnostic Inc., 
Stanford, CT). Briefly, after shear exposure, cells were washed twice (PBS), trypsinized 
and collected. After normalizing the cell count, EC were resuspended in 0.1% Triton X-
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100 (in TBS) and lysed by sequential freeze-thaw cycles (3X, 30min freezing at -80˚C 
followed by 30min thawing at 37˚C water bath). Cell membrane and debris were 
removed by centrifugation, and the supernatant containing cytosol proteins was collected. 
The samples were then applied to a 96-well microtiter plate pre-coated with mouse 
monoclonal TF capture antibody (overnight at 4˚C). The wells were washed with wash 
buffer (PBS with 0.1% Triton X-100, pH 7.4) and incubated with biotinylated anti-human 
TF F(ab’)2 antibody (60min at RT). After washing, antibody binding was detected using a 
streptavidin conjugated horseradish peroxidase (60min at RT) and developed using a 
tetramethylbenzidine (TMB) substrate. The reaction was stopped after 20min using 0.5M 
H2SO4 and color development was measured at 450nm using a microplate reader.   
4.3.3.3 mRNA expression using RT-PCR 
Shear stress-induced changes in TF and TM mRNA expression was measured 
using RT-PCR (as described before). The forward and reverse primers used for TF were 
5'-GCGCTTCAGGCACTACAAATACT-3' and 5'- 
CCTGACTTAGTGCTTATTTGAACAGTGT-3' respectively, while those for TM were 
5' - CTCATAGGCATCTCCATCGCG -3' and 5' - CCGCGCACTTGTACTCCATCT -3' 
respectively. β-actin was used as endogenous control.  
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4.3.4 Shear stress induced EC platelet adhesion receptor – von Willebrand factor 
(vWF) expression 
4.3.4.1 Surface protein expression using ELISA 
Shear stress induced changes in EC surface vWF expression was measured using 
a solid phase ELISA as described above, using a monoclonal murine anti-human vWF 
antibody.  
4.3.4.2 Total protein expression using Western Blot 
Post shearing, changes in EC total vWF expression was measured using Western 
blot as described before. A rabbit polyclonal anti-human vWF was used as the primary 
antibody (1μg/mL) to detect total vWF. Primary antibody binding was detected using a 
HRP conjugated goat anti-rabbit secondary antibody (1μg/mL) and developed using ECL 
substrate. 
4.3.4.3 mRNA expression using RT-PCR 
As described before, shear stress induced changes in vWF expression was 
measured using RT-PCR. The forward and reverse primers were 5'-
GTTCGTCCTGGAAGGATCGG-3' and 5'-CACTGACACCTGAGTGAGAC-3' 
respectively. β-actin was used as endogenous control.  
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4.4 Effect of dynamic shear stress on platelets 
Typical platelet shear stress histories (waveforms shown in Figure 15) obtained 
from numerical simulations were applied to platelets in vitro in the cone and plate 
shearing device. Platelets were exposed to three specific shear stress waveforms 
including normal (represents shear stress on platelets passing through a normal LCA, 0.1-
1Pa), high magnitude pulsatile (platelet passing through the stenosis once every 90 sec, 
normal shear with intermediate exposure to 6Pa for 0.1 sec once every 90 sec) and low 
magnitude unidirectional shear (platelet caught in recirculation zone downstream of the 
stenosis, 0.04-0.1Pa) waveforms. In general, the concentration of platelets is higher near 
the vessel wall compared to that in the core flow. Therefore shear stress history of 
platelets that travel close to the vessel wall was chosen, which was very similar to the 
wall shear stress history used for endothelial cells.  The major difference between EC and 
platelet shear stress history was in the stenosis shear waveforms. EC, due to their fixed 
spatial location, were continuously exposed to a peak shear of 6Pa every cardiac cycle. 
However, as platelets traveled through the stenosis throat they were momentarily exposed 
to a peak shear of 6Pa. As they passed the stenosis region, they were exposed to 
physiological level shear stress.  We assumed that platelets traveled through the same 
stenosis throat once every 90 sec.  
Pulsatile shear-induced platelet activation was measured by their ability to 
generate thrombin, using a modified prothrombinase assay. This experiment was 
conducted in our lab as a part of a study published earlier by Yin et al
4
. In the present 
study, shear stress-associated platelet complement activation was measured through 
platelet surface C1q, C4d, iC3b and sC5b-9 expression. Changes in platelet proteomic 
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profiles induced by shear stress was examined using the surface enhanced laser 
desorption ionization (SELDI) ProteinChip reader. 
 
 
 
 
 
 
 
 
 
 
Figure 15. Shear stress history (3 cardiac cycles) on platelet passing through LAD 
under different conditions. Normal - platelet passing through healthy LAD, Stenosis - 
Platelet passing through 80% stenosis artery and Recirculation - platelet trapped 
inside recirculation zone. 
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4.4.1 Materials used 
Antibodies: Mouse monoclonal anti-human C1q, C4d, iC3b and sC5b-9 (1μg/mL, Quidel 
Corporation, San Diego, CA) antibodies were used to measure platelet surface deposition 
of complement proteins – C1q, C4d, iC3b and sC5b-9. FITC conjugated goat anti-mouse 
secondary antibody (Sigma) was used to detect primary antibody binding for flow 
cytometry measurements. Non-specific binding was detected by incubating platelets with 
FITC-conjugated MOPC (Ancell Corporation, Bayport, MN). For ELISA, the primary 
antibody binding was detected using an alkaline phosphatase conjugated goat anti-mouse 
secondary antibody (Sigma-Aldrich). Platelet surface complement receptor–1 (CR1) 
expression was detected using a monoclonal murine anti-human CD35 antibody (Ancell).  
Buffers:  
 Hepes Buffered Modified Tyrode’s solution (HBMT) 
 0.5% glutaraldehyde 
 100mM glycine with 0.1% BSA 
 Tris-Buffered Saline (TBS) (described above) 
 Phosphate-Buffered Saline (PBS) (described above) 
 ProteinChip CM low-stringency buffer: 0.1M sodium acetate, pH 4.0 (BioRad) 
4.4.2 Platelet associated complement activation 
4.4.2.1 Platelet surface complement protein deposition 
Washed platelets were exposed to above mentioned pulsatile shear stress 
waveforms for 30min and platelet complement activation (surface deposition of 
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complement protein C1q, C4d, iC3b and sC5b-9) was measured using a solid-phase 
ELISA. Platelets were sheared for only 30 minutes, as significant changes in platelet 
complement response were detected. Briefly, sheared platelet samples were immobilized 
into a 96-well microtiter plate pre-coated with poly-L-lysine (10µg/mL, 30min at 37˚C), 
fixed with 0.5% glutaraldehyde (15min, 37˚C) and blocked using 100mM glycine – 0.1% 
bovine serum albumin (BSA, 99% fatty acid free, Sigma-Aldrich). After washing (TBS), 
platelets were incubated with human plasma (PPP diluted 1:10 in HBMT, 60min, 37˚C). 
Platelet complement protein deposition was measured by incubating the samples with 
murine monoclonal anti-human C1q, C4d, iC3b and sC5b-9 antibodies (1:200 in HBMT, 
60min, 37˚C). Primary antibody binding was detected using an alkaline phosphatase 
conjugated goat anti-mouse secondary antibody (1:1000 in HBMT, 60min 37˚C). Finally, 
complement protein deposition was developed using a p-nitrophenyl phosphate substrate 
(pNPP, 1mg/mL) (Pierce Biotechnology, Inc.) and measured at 405nm in a microplate 
reader.  
Alternatively, complement protein deposition on platelets in fluid phase was 
measured using flow cytometry. Post shearing, platelet samples were treated with plasma 
in suspension (60min, 37˚C) and washed twice by centrifugation (1000xg, 5min). The 
samples were then incubated with murine monoclonal anti human C1q, C4d, iC3b and 
sC5b-9 antibodies (1:100, 30min, RT); primary antibody binding was detected using a 
FITC conjugated goat anti-mouse secondary antibody (1:100, 30min, RT). After 
incubation, platelet samples were fixed in 1% paraformaldehyde (AlfaAesar, MA) and 
read in a flow cytometer (Accuri C6, Ann Arbor, MI). Resting platelets were used as 
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negative control, while platelets incubated with MOPC antibody was used to measure 
non-specific binding.  
4.4.2.2 Activation of complement inhibitors 
The complement system is highly regulated by a set of complement inhibitors. 
For instance, C1 inhibitor (C1-inh) can form a covalent 1:1 complex with both C1r and 
C1s (sub-units of C1 complex) and prohibit the formation of C1 complex
96
. Similarly, 
complement receptor 1 (CR1) interacts with C3b and C4b, and regulates both classical 
and alternative pathway of complement cascade
71
. The amount of C1-inhibitor (C1-INH) 
released during shearing was also measured. After shearing, the platelet samples were 
centrifuged (3000rpm, 6min) and the supernatant was collected and assayed for C1-INH, 
using a C1-inhibitor ELISA kit (Quidel Corporation, San Diego, CA). Briefly, the 
samples were diluted 1:10 in specimen dilutent (0.035% ProClin 300 in PBS) and 
incubated with biotin conjugated C1-INH reactant to form C1-inhibitor:C1 reactant 
complex (C1-INH complex), which was fixed to avidin pre-coated microtiter wells. After 
washing (0.05% Tween20 and 0.035% ProClin 300 in PBS), the fixed C1-INH complex 
was incubated with HRP conjugated anti human C1-INH antibody. The samples were 
then treated with a chromogenic substrate and color development was read at 405nm 
using a microplate reader. Based on a standard curve, the amount of C1-INH released by 
platelets during shearing was quantified.  
Shear-induced changes in platelet surface complement receptor 1 (CR1) 
expression was measured using a solid phase ELISA as described earlier, using a 
monoclonal murine anti-human CD35 antibody.   
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4.4.3 Platelet proteomics 
  Platelets stimulated with shear stress were examined for changes in proteomic 
profiles using the SELDI ProteinChip reader (BioRad, Hercules, CA). Washed platelets 
were exposed to two different types of shear stress conditions – constant shear (1 and 
3Pa) and dynamic shear (normal, low magnitude unidirectional and high magnitude 
pulsatile shear) for 60min as described above. After treatment, platelet samples were 
washed with 0.9% NaCl containing 10mM EDTA (by centrifugation 1000xg) and 
resuspended in platelet lysis buffer (0.1% Triton X-100 in PBS) containing proteolytic 
inhibitors (1µg/mL aprotinin, 1μg/mL leupeptin and 1mM PMSF). After incubating on 
ice for 60 min, the insoluble cell membrane components were discarded by centrifugation 
(12000xg) and the cell lysate was collected and stored at -80˚C until use. Resting 
platelets were used as control, while platelets treated with thrombin receptor activator 
peptide (20μM TRAP, 5min, RT) were used as the positive control.  
A weak cation exchange chromatographic substrate (CM 10 ProteinChip Array 
shown in Figure 16, BioRad) was prepared by washing the substrate with low stringency 
binding buffer (pH 4.0, BioRad). The lysate samples were then applied to these pre-
activated surfaces and incubated at room temperature for 60min. After removing excess 
samples, the binding spots were washed using a CM low-stringency binding buffer 
(BioRad, 3X), followed by deionized water (2X). The chromatographic spots were 
allowed to air dry (~5 min, RT) and embedded in an electron-absorbing sinapinic acid 
energy absorption matrix (SPA-EAM, BioRad).  The matrix was prepared by diluting 
lyophilized EAM in equal volumes of 1% trifluoracetic acid (Fisher Scientific) and 
sinapinic acid (Sigma). The ProteinChip arrays were then read in the SELDI ProteinChip 
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reader (BioRad). The threshold range was kept at 1500Da (corresponding to SPA-EAM 
matrix noise) and the signal to noise ratio was kept at 3.0. Based on the time of flight data 
collected, protein mass over charge (m/z) ratio was estimated. The m/z data was 
calibrated using a known peptide calibration chip containing 6 different peptide peaks in 
the range of 2-20KDa (BioRad) under same conditions. The peptide calibration peaks 
included Arg8-vasopressin (1084.25Da), somatostatin (1637.90Da), dynorphin A 
(2147.5Da), ACTH (3465Da), Beta endorphin (3465Da), Arg-insulin (5963.8Da) and 
cytochrome C (12230.92Da). Small proteins/peptides in the range of 2 to 20kDa (m/z) 
were of special interest in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
Figure 16. (A) SELDI protein chip with chromatographic spots/surface on which the 
samples were applied. (B) Capture of biological samples on a chromatographic 
surface. 
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The spectral data was analyzed using the ProteinChip data management software 
(BioRad). Baseline of each spectrum was adjusted to offset noises, and all spectral peaks 
were normalized. Spectral profiles obtained from sheared and resting platelet were 
compared by using peak cluster analysis provided by the software. Signal to noise ratio 
was set at 5 and mass tolerance at 0.3%. For statistical analysis, peak intensity was used.  
4.5 Effect of dynamic shear stress on EC – platelet interaction 
To examine how platelet-EC interaction affected cell responses to dynamic shear 
stress, confluent HCAEC were exposed to various shear stress waveforms in the presence 
of washed platelets (250,000/µL) in vitro in a cone and plate shearing device or a 
parallel-plate flow chamber. As discussed earlier (Section 4.4), normal and low 
magnitude unidirectional shear waveforms were similar for both EC and platelets. The 
high magnitude pulsatile shear was different for EC and platelets (shown in Figures 14 
and 15). To study interaction, the platelet high magnitude pulsatile shear waveform was 
used in the coupled cone and plate shearing system. In the cone and plate shearing 
system, since shear stress was uniform everywhere, using the EC high shear waveform 
would have led to a significantly increased shear stress loading (shear-time integral) on 
suspended platelets, which  might potentially induce fast cell activation or damage
3
. 
Hence the platelet high shear waveform was used for coupled shearing experiments. 
Effects of shear stress and cell-cell interaction on EC activation, EC inflammatory 
response, platelet thrombogenicity, and platelet complement activation were examined.   
In the parallel-plate flow chamber, platelets and EC experienced different shear 
stress at the same flow rate. For platelets in the fluid phase, cells that were moving close 
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to the top and bottom boundary of the chamber experienced higher shear stress, while 
cells moving in the center of the chamber were exposed to a lower shear stress (as shown 
in Section 4.2 and Equation 4.8). For EC that were attached to the bottom of the chamber, 
as flow was fully developed (as described in Section 4.2), shear stress exerted on the cells 
was uniform and was proportional to the flow rate. The parallel-plate flow chamber 
provided a more physiological experimental setup to investigate direct interaction 
between EC and platelets under dynamic shear stress conditions. However, with platelets 
and EC exposed to different shear stress, the complexity of the experiment significantly 
increased. Flow rate in the chamber was adjusted to mimic normal (0-200mL/min), low 
(0-90mL/min) and high (0-660mL/min) magnitude pulsatile shear environment, with the 
maximum shear stress of 1, 0.4, and 3Pa generated on the bottom of the chamber on EC, 
respectively. To examine the effect of dynamic shear stress and platelet-EC interaction on 
individual cell responses, platelet adhesion to EC was directly examined using 
immunofluorescence microscopy.    
4.5.1 Materials used 
Antibodies: Alexa fluor 488 conjugated Phalloidin against F-actin (Invitrogen, Grand 
Island, NY), DAPI nucleic acid stain (Invitrogen) and TRITC conjugated antibody 
against GPIbα (CD42b, Ancell) were used to detect platelet adhesion to EC using 
immunofluorescence microscopy. PECAM-1 expression on both EC and platelets was 
detected using TRITC conjugated anti-human CD31 antibody (Ancell). Mouse IgG1 
Kappa (MOPC) conjugated with FITC and TRITC was used as isotype negative control.  
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4.5.2 EC response to dynamic shear stress in the presence of platelets 
EC and platelets were exposed to various shear stress waveforms simultaneously 
for 60min. After shearing, platelets were removed from the coupled-shearing system and 
EC were washed gently in PBS (2X). EC response was measured by cell surface ICAM-1 
and TF expression using a solid phase ELISA approach (as described before); and EC 
ICAM-1 mRNA expression was measured using RT-PCR (as described before). In a 
parallel work conducted by other lab members, EC surface TM and vWF expression was 
examined after co-shearing with platelets, and no significant change was observed under 
all three shear conditions.  
4.5.3 Platelet response to dynamic shear stress in the presence of EC 
After exposed to shear stress with EC, platelet samples were removed from the 
coupled shearing system and platelet thrombogenicity was measured using a modified 
prothrombinase assay (PAS)
97
. In a previous study conducted by other lab members, 
platelets were exposed to all three pulsatile shear waveforms alone and their 
thrombogenicity was measured using PAS assay
4
, which measured acetylated thrombin 
generation from acetylated prothrombin. This previous study demonstrated that after 
30min of shear exposure high magnitude shear induced an elevated rate of thrombin 
generation compared to normal shear but no change was observed under low magnitude 
shear. However, at the end of 30min, low magnitude shear induced a 50% increase in 
thrombin generation compared to normal shear. This result indicated that a longer 
exposure to low magnitude shear could potentially lead to elevated platelet activation.  
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Here, similar experiments were conducted in the presence of EC to investigate if 
platelet-EC interaction would affect platelet response to dynamic flow conditions. 
Acetylated thrombin did not have a positive feedback on platelet activation, thus 
provided a one-to-one relationship between shear stress and thrombin generation. After 
shear exposure, platelet samples (collected from the shearing device) were incubated with 
factor Xa (100pM, Enzyme Research, MO), acetylated prothrombin (200nM, Enzyme 
Research) and CaCl2 (50μM) for 10min at 37˚C. The amount of thrombin generated was 
quantified using a chromogenic substrate (Chromozym-TH, Roche Applied Sciences, IN) 
and the color development was measured at 405nm.  Resting platelets incubated with EC 
were used as control. 
 In addition, to examine the effect of cell interaction on platelet complement 
response to dynamic flow, platelet samples were removed from the coupled shearing 
system and examined for their surface C1q deposition using flow cytometry (as described 
above). Resting platelets incubated with untreated EC were used as control.  
EC (activation/inflammation) and platelet (activation, complement protein 
deposition) responses measured from these coupled shearing experiments were compared 
to those obtained from single cell shearing experiments.  
4.5.4 Platelet adhesion to EC under dynamic shear stress 
 Platelet adhesion/deposition on EC was measured using immunofluorescence 
microscopy.  
Following shear exposure, platelets were removed from the system. EC were 
washed gently with PBS (2X), followed by fixation in 0.5% glutaraldehyde (15min, 
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37˚C) and neutralized with glycine-0.1% BSA (30min, 37˚C). Platelets adhered to EC 
monolayer were detected using a TRITC (red) conjugated GPIbα antibody (Ancell) 
(10min, RT).  After washing with PBS (2X), cells were permeablized with 1% Triton X-
100 (5min, RT), and incubated with phalloidin (green, Alexa Fluor 488, Invitrogen) to 
detect F-actin in both EC and platelets (20min, RT). DAPI (blue) was used to detect EC 
nuclei (Invitrogen) (5 min, RT). The cells were washed (2X) and immediately examined 
using a fluorescence microscope (Nikon TE 2000U). Fluorescent images were captured at 
random locations using a Coolsnap fast cooled (ES2) digital camera interfaced with NIS 
Elements Software (Nikon). By overlaying images from different excitation, platelet 
adhesion was identified by co-localization of GPIbα and actin. Further, deposition of 
platelets or platelet microparticles was characterized (by size) by examining higher 
magnification images (up to 100X). Non-specific binding was probed using 
FITC/TRITC-MOPC binding. In addition, amount of platelet binding was quantified by 
measuring the ratio of area covered by platelets to the total image area using ImageJ 
(v1.46, NIH). By adjusting the image contrast platelet deposited area was isolated. After 
converting the image from RGB to black and white, the total area covered by platelets 
was quantified.  
Due to the abundance of actin filaments in cytoskeleton, the fluorescence signal 
from actin staining might be overwhelming. Therefore, alternatively, the cells were 
incubated with TRITC conjugated anti-human CD31 antibody (to detect PECAM-1 on 
both EC and platelets). PECAM-1 is regarded as one of the potential target 
mechanosensing protein that is present on the membrane of both EC and platelets
98
.  
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GPIbα is one of the key ligands that are involved in platelet adhesion to EC, 
through EC surface receptor vWF. To investigate whether GPIbα-vWF binding is 
responsible for platelet adhesion to EC and other related changes under dynamic shear 
stress, platelet GPIbα was blocked using a mouse anti-human GPIbα blocking antibody 
(30min, RT) before coupled shearing. In addition, platelet membrane GPIIb/IIIa is also 
involved in platelet adhesion to EC through vWF or ICAM-1 (secondary binding through 
fibrinogen). Platelets were incubated with tirofiban (50ng/mL, 5min RT) to block surface 
GPIIb/IIIa before being exposed to shear stress in the presence of EC. After shearing, EC 
were washed and incubated with TRITC-conjugated PECAM-1 antibody to detect 
platelet binding, and EC nuclei were detected using DAPI.  
The adhesion studies were conducted using both the cone and plate shearing 
device and the parallel-plate flow chamber. For the cone and plate shearing device, EC 
were cultured directly on the 6-cm petri dish, and for the parallel-plate flow chamber, EC 
were cultured on coverslips (22 X 40 mm) and placed inside the chamber after EC were 
confluent. To achieve required high shear stress inside the chamber, washed platelet 
viscosity was increased by adding dextran (3% by weight). Using flow cytometry, no 
change in platelet activation (surface CD62P expression) was detected due to addition of 
dextran.  
4.6 Statistics 
The statistical analysis of the data obtained from all experiments were carried out 
using one way ANOVA or Student’s t-test based on the treatment conditions. All 
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statistical analysis was conducted using the Primer of Biostatistics software package 
(v4.02, McGraw Hill) and Excel (Office 2010). 
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CHAPTER V 
 
 
RESULTS 
 
5.1 CFD analysis of coronary flow 
 A physiologically realistic 3D human left coronary artery model was developed 
using ANSYS CFX. Blood flow inside the artery was simulated under normal and disease 
conditions, i.e., 30%, 60% and 80% constriction in the LAD branch. The velocity and 
shear stress distribution, over one cardiac cycle, inside the LAD branch was estimated
99
. 
The main region of interest was the area in the LAD near the bifurcation, which is a well-
established athero-prone region
16
. The velocity vector distribution (Figure 17) in this 
region indicated that flow was skewed towards the wall close to the bifurcation (20mm 
downstream from the bifurcation), resulting in a high velocity gradient. In contrast, the 
outer LAD wall away from the bifurcation experienced flow separation and lower 
velocity gradient. As the stenosis severity progressed, the magnitude of the mean 
centerline velocity at the stenosis throat increased from 19.65cm/sec under normal 
condition to 23.96cm/sec, 35.16cm/sec and 62.93cm/sec under 30%, 60% and 80% 
stenosis condition, correspondingly.  
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5.1.1 Estimation of wall shear stress history 
Wall shear stress (WSS) along the LAD wall was calculated based on the velocity 
gradient and local effective viscosity. The major regions of interest inside LAD included 
oscillatory zone near the bifurcation, high shear stress area around the stenosis throat, and 
recirculation zone downstream of the stenosis. The contours of wall shear stress 
distribution (at t = 0.8 sec) near the regions of interest are shown in Figure 18. Wall shear 
stress history over one cardiac cycle (t = 0.9 sec), at every single node (of wall elements) 
in these regions was calculated. Some of the representative wall shear stress history 
waveforms at different locations were depicted in Figure 13 in the Methods section.  
These shear stress waveforms represent: 1) physiological pulsatile shear, which varied 
between 0.1-1Pa; 2) low magnitude unidirectional shear representing shear stress 
variation on LAD wall inside the recirculation zone, which varied between 0.01-0.4Pa; 3) 
low magnitude bidirectional shear representing wall shear stress variation inside the 
oscillatory shear zone opposite to the bifurcation, which varied between±0.3Pa; and 4) 
high magnitude pulsatile shear representing shear stress variation at the stenosis throat 
(60% severity), which varied between 0.1-6Pa once every cardiac cycle. The calculated 
shear stress waveforms were exported to a cone and plate shearing device or a parallel-
plate flow chamber to conduct in vitro experiments on EC. 
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Figure 17. Velocity vector distribution inside LAD under (A) Normal, (b) 30% stenosis, (C) 
60% Stenosis and (D) 80% stenosis condition. The vectors are representative of maximum 
inlet velocity at t = 0.8 sec.  
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Figure 18. Wall shear stress contours on LAD wall under (A) Normal, (b) 30% stenosis, 
(C) 60% Stenosis and (D) 80% stenosis condition. The shear stress distribution is 
representative of maximum inlet velocity at t = 0.8 sec.  
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5.1.2 Estimation of platelet trajectory and shear stress history 
 Platelets seeded at the entrance of LCA were tracked at every time step and their 
trajectory was calculated using ANSYS CFX. Some representative platelet trajectories 
were plotted under both normal and disease conditions and shown in Figure 19. Shear 
stress applied to platelets along their trajectory was calculated using a discrete phase 
model. Platelets that were moving close the vessel wall were generally exposed to higher 
shear stress and had a higher chance to adhere to the vessel wall. Hence typical shear 
stress history of platelets that were travelling close to the blood vessel wall was chosen to 
direct the in vitro studies, which were depicted in Figure 15 in the Methods section. The 
three shear waveforms used in this study were 1) physiologically normal shear waveform, 
describing a platelet traveling through a normal LAD, which varied between 0.1-1Pa; 2) 
pathologically low magnitude unidirectional shear representing a platelet trapped inside 
the recirculation zone downstream of a stenosis, which varied between 0.01-0.4Pa; and 3) 
high magnitude pulsatile shear mimicking shear stress on a platelet traveling through a 
60% stenosis very close to the wall once every 90sec, where the waveform had a peak 
shear of 6.5Pa for 0.1sec once every 90sec.  
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Figure 19. Platelet trajectory inside LAD under  (A) Normal, (b) 30% stenosis, (C) 60% 
Stenosis and (D) 80% stenosis condition. The trajectories are representative of maximum 
inlet velocity at t = 0.8 sec.  
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5.2 Effect of dynamic shear stress on endothelial cells  
Confluent monolayers of human coronary artery endothelial cells (HCAEC) were 
exposed to the four dynamic shear stress waveforms (Figure 13) using a cone-plate 
shearing device. Post shearing, cells were examined for their surface and total expression 
of athero-genic/protective protein markers including ICAM-1, TF, TM and vWF. In 
addition, changes induced by shear stress at mRNA level was also measured.  
5.2.1 EC activation – ICAM-1 expression 
EC were exposed to all four shear stress waveforms for 60min. EC surface 
ICAM-1 expression was measured using a solid phase ELISA.  The results are presented 
in Figure 20A as normalized OD values (normalized to untreated EC).  Compared to 
normal shear stress, low magnitude unidirectional shear stress induced a slight increase in 
ICAM-1 expression (Mean ± SD: 1.32±0.16, n=5 for normal, and 1.38±0.44 for low 
unidirectional shear, n=4), but no statistical significance was detected. Oscillatory shear 
stress induced a reduction in ICAM-1 expression (1.04±0.08, n=5) compared to normal 
shear, but no statistical significance was detected. EC exposed to high magnitude shear 
stress had a significant (P<0.05) reduction in ICAM-1 expression (0.82±0.11, n=5), 
compared to both normal and low magnitude unidirectional shear stress.  
In addition, shear stress induced changes in EC total ICAM-1 expression were 
measured using Western blot techniques. The results (normalized band intensity) 
revealed an elevated ICAM-1 total protein expression in EC exposed to low 
unidirectional and oscillatory shear conditions. EC exposed to high magnitude pulsatile 
shear had a reduction in ICAM-1 expression. Representative images of the protein bands 
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are shown in Figure 21. For all experiments, the band intensity was quantified using spot 
densitometry and the average band intensity normalized to control is presented in Figure 
20B. The intensity data indicated that the low magnitude unidirectional (Mean± SD: 
1.35±0.29) and bidirectional shear (1.52±0.21) induced a statistically significant (p<0.05, 
n=4-5) increase in ICAM-1 expression compared to normal shear (0.96±0.37), while high 
magnitude pulsatile shear (0.66±0.11) led to a significant reduction in ICAM-1 
expression.   
 To measure the changes in ICAM-1 at mRNA levels, post shearing (60 min), total 
cellular mRNA from each sample was isolated and examined using RT-PCR. Figure 20C 
represents the relative change in ICAM-1 expression (relative to β-actin) under four 
different dynamic wall shear stress conditions. ICAM-1 mRNA levels did not change 
under both low magnitude unidirectional (Mean ± SD: 2.34±0.78, n=6) and bidirectional 
(2.32±0.46, n=5) shear compared to normal shear (2.48±0.74, n=5). However, high 
magnitude pulsatile shear (1.42±0.68, n=6) induced a significant reduction in ICAM-1 
mRNA expression compared to all the other shear conditions.  
These results demonstrated that EC were sensitive to the variation in dynamic 
shear stress, in terms of ICAM-1 expression. Overall, low pathological shear stress could 
potentially increase EC ICAM-1 expression, while elevated shear stress would reduce 
ICAM-1 expression. 
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A. EC surface ICAM-1 expression 
B. EC total ICAM-1 expression 
C. EC ICAM-1 mRNA expression 
Figure 20. Shear stress induced changes in EC ICAM-1 expression at surface (A, 
using ELISA), total (B, using western blot) and mRNA (C, RT-PCR) levels. Data 
is presented as Mean± SD normalized to untreated EC.  
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Figure 21. Representative Western blot showing ICAM-1 total protein 
concentration under different shearing conditions. 
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5.2.2 EC injury response – TF and TM expression 
 Dynamic shear stress-induced changes in EC inflammatory response were 
investigated by measuring changes in the surface expression of tissue factor (TF) using 
solid phase ELISA. Figure 22A represents the normalized O.D. value of TF expression 
under dynamic shear stress. For tissue factor expression, none of the pathological shear 
stress waveforms (low unidirectional, high magnitude, and oscillatory) led to any 
significant changes compared to physiological pulsatile shear stress. While among the 
three pathological shear conditions, oscillatory shear (Mean ± SD: 0.91±0.26, n=5) 
induced a statistically significant reduction (P<0.05) in TF expression compared to low 
magnitude unidirectional shear (1.425±0.153, n=4).  
For total protein expression, using Western blot, no tissue factor bands were 
detected in cell lysates (Figure 23). Since clear TF bands were visible when recombinant 
TF was used, it was suspected that majority of TF was localized to the cell membrane 
which was discarded during the cell lysate preparation, and hence the remaining cytosolic 
TF protein concentration was minimal and could not be detected by Western blot. 
Therefore an alternative approach was taken to measure EC total tissue factor expression 
using a TF sandwich ELISA kit. Changes in total TF protein concentration is presented as 
normalized O.D. value (normalized to unsheared EC) in Figure 22B.  Compared to 
normal shear (Mean ± SD: 1.451±0.154, n=4), both low magnitude unidirectional 
(1.067±0.035, n=4) and bidirectional (1.198±0.118, n=3) shear stress induced a 
significant (P<0.05) reduction in total TF expression. 
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In addition, TF expression was also measured at the mRNA level (Figure 22C). 
For TF mRNA expression, EC exposed to low magnitude unidirectional (Mean ± SD: 
0.65±0.08, n=5) and high magnitude pulsatile shear (0.79±0.21, n=4) induced a 
statistically significant decrease compared to normal shear (2.78±0.94, n=6). Low 
magnitude bidirectional shear (2.30±0.57, n=4) induced no change in TF mRNA 
expression compared to normal shear, while significantly increased TF mRNA 
expression compared to low magnitude unidirectional and high magnitude pulsatile shear 
stress.  
Together these results indicated that EC were sensitive to variation in dynamic 
shear stress. Even though responses (TF expression) we observed here were not 
consistent at the surface protein, total protein and mRNA level, it was clear that EC could 
respond to various pathological dynamic shear stress differently in terms of TF 
expression.    
Similarly, EC surface TM expression was examined using solid phase ELISA. 
The results are summarized in Figure 24A. A statistically significant decrease was 
observed under low magnitude unidirectional (1.00±0.19, n=7), bidirectional (0.91±0.01, 
n=5) and high magnitude pulsatile shear (0.97±0.08, n=7), when compared to normal 
shear (1.19±0.2, n=6).  
 Further, shear stress induced changes in EC total TM protein expression was 
measured using Western blot. The protein bands (at 74KDa) developed on the blots 
indicated that all dynamic shear stress induced a slight decrease in TM expression, 
compared to normal pulsatile shear stress  (representative blot shown in Figure 25).  The 
86 
 
spot densitometry analysis (Figure 24B) revealed that the TM expression on low 
magnitude unidirectional (Mean ± SD: 1.10±0.15, n=3), bidirectional (1.09±0.16, n=3), 
and high magnitude pulsatile shear (1.34±0.14, n=3) was slightly reduced compared to 
normal shear (1.41±0.25, n=3). No statistical significance was detected.   
No significant changes in TM mRNA expression were detected under any 
pathological dynamic shear conditions, compared to the normal pulsatile shear stress. 
(Figure 24C).  
These results suggested that the exposure to pathological dynamic shear stress 
conditions led to changes (mostly reduction) in EC TM expression, compared to 
physiological pulsatile shear. This indicated that EC were sensitive to changes in 
dynamic shear stress, and could respond differently in terms of TM expression. 
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A. EC surface TF expression 
B. EC total TF expression 
C. EC TF mRNA expression 
Figure 22. Shear stress induced changes in EC TF expression at surface (A, using 
ELISA), total (B, using sandwich ELISA) and mRNA (C, RT-PCR) levels. Data 
is presented as Mean + SD. 
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Figure 23. Representative western blot showing TF total protein concentration 
under different shearing conditions. As a positive control recombinant TF was 
used in the assay to validate the experimental design.  
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A. EC surface TM expression 
B. EC total TM expression 
C. EC TM mRNA expression 
Figure 24. Shear stress induced changes in EC TM expression at surface (A, 
using ELISA), total (B, using western blot) and mRNA (C, RT-PCR) levels. Data 
is presented as Mean + SD.  
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Figure 25. Representative western blot showing TM total protein concentration 
under different shearing conditions. 
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5.2.3 EC vWF expression 
 EC directly interact with circulating platelets through surface von Willebrand 
Factor (vWF) expression. Shear stress-induced changes in EC surface vWF expression 
was measured using solid phase ELISA. The results (presented in Figure 26A) indicate 
that the low magnitude unidirectional (Mean ± SD: 1.11±0.27, n=7) and oscillatory shear 
(1.12±0.22, n=5) induced an upregulation of surface vWF expression compared to normal 
shear (1.00±0.31, n=6), however no statistical significance was detected. High magnitude 
pulsatile shear (1.00±0.2, n=7) did not induce any changes in surface vWF expression 
compared to normal shear.  
 EC total vWF expression was measured using Western blot. No significant 
changes in EC total vWF expression was detected. The intensity data is presented in 
Figure 26B and a representative blot is presented in Figure 27. 
In addition, vWF mRNA expression was measured on EC exposed to all four 
dynamic shear stress waveforms. The relative mRNA expression values are presented in 
Figure 26C. Except the low magnitude unidirectional shear stress (Mean ± SD: 
2.23±0.71, n=6, P<0.05), none of the pathological dynamic shear stress induced any 
changes in EC vWF mRNA expression compared to normal shear (0.85±0.27, n=5).   
   Overall, these results suggest that EC did not respond to various dynamic shear 
stress conditions in terms of vWF expression. Altered shear stress did not have effect on 
vWF expression, or EC capability in accepting platelet binding.  
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A. EC surface vWF expression 
C. EC vWF mRNA expression 
B. EC total vWF expression 
Figure 26. Shear stress induced changes in EC vWF expression at surface (using 
ELISA), total (using western blot) and mRNA (RT-PCR) levels. Data is 
presented as Mean + SD. 
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Figure 27. Representative western blot showing vWF total protein concentration 
under different shearing conditions. 
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5.3 Effect of dynamic shear stress on platelets 
Platelets were exposed to three different shear stress waveforms in vitro using a 
cone and plate shearing device. The three waveforms (Figure 14) were selected from 
CFD simulations representing platelet passing through normal LAD near the vessel wall 
(referred to as normal), platelet passing through a 60% stenosis throat (once every 90 sec) 
(referred as high magnitude pulsatile shear), and platelets trapped inside the recirculation 
zone (referred to as low magnitude pulsatile shear).  
Effects of these three dynamic shear stresses on platelet activation in vitro was 
studied and reported previously
4
. It was demonstrated that the rate of thrombin generation 
was not statistically significant under both low and high magnitude pulsatile shear 
compared to normal shear. However, flow cytometry measurement on platelet surface 
CD62P expression demonstrated that platelets exposed to all three dynamic shear stresses 
were not activated
100
. These results indicated platelets were not sensitive to changes in 
dynamic shear stress patterns, in terms of CD62P expression, or cell activation; but 
dynamic shear stress at any level was able to lead to thrombin generation, if shear 
exposure time was adequate.  
5.3.1 Platelet complement activation 
5.3.1.1 Platelet surface complement protein deposition 
Post shearing, platelets were fixed to 96-well microtiter plates, incubated with 
human plasma and were examined for surface complement protein C1q deposition using 
solid phase ELISA (Figure 28). The results indicated that the platelets that were exposed 
to low magnitude pulsatile shear stress (Mean ± SD, 1.26  0.06, p<0.05, n=9) had a 
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significant increase in C1q deposition compared to normal shear (1.07±0.09, n=9), while 
no noticeable changes were observed under high magnitude pulsatile shear. To determine 
if complement activation would proceed to completion, platelet surface deposition of 
other complement cascade proteins –C4d, iC3b, and SC5b-9 were examined using a 
similar solid phase ELISA approach. The results (Figure 29) revealed noticeable increase 
in C4d deposition under pathological shear stress conditions (0.81±0.19, n=9 for normal; 
0.97±0.13, n=6 for low unidirectional; 0.91±0.04, n=8 for high magnitude pulsatile), but 
no significant changes were detected between the conditions. These results indicated that 
the downstream complement cascade was completely inhibited.  
Alternatively, platelet surface complement C1q expression was measured in the 
fluid phase using flow cytometry.  The representative fluorescence histogram is presented 
in Figure 30. Resting platelets (not exposed to shear stress) were used as experimental 
control, while MOPC was used to measure non-specific antibody binding. The results 
indicated that platelets exposed to low magnitude unidirectional shear expressed an 
elevated C1q deposition (population shift in fluorescence histogram shown in Figure 30) 
compared to both normal and high magnitude pulsatile shear (P<0.05). The normalized 
all mean fluorescence values quantifying complement C1q deposition from flow 
cytometry is summarized in Table 3. Similarly, no significant change in downstream 
complement protein (C4d) expression was detected using flow cytometry (mean 
fluorescence value shown in Table 3). To reduce the variation in platelet complement 
response from different donors, the all mean fluorescence value was normalized to that of 
resting platelets on the same day. 
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Figure 28. Normalized (to resting platelets) platelet surface C1q expression 
measured using solid phase ELISA. Data is presented as Mean + SD. 
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Figure 29. Normalized (to resting platelets) platelet surface C4d, iC3b and 
sC5b-9 expression measured using solid phase ELISA. Data is presented as 
Mean + SD. 
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Figure 30. Representative histogram data representing changes in platelet 
surface C1q deposition measured using flow cytometry. 
Table 3. Normalized all mean fluorescence value of platelets exposed to normal, 
Low magnitude unidirectional and high magnitude pulsatile shear. 
Surface C1q expression 
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5.3.1.2 Activation of complement inhibitors     
The activation of the complement system is regulated by a set of complement 
inhibitors including C1-inhibitor (C1-INH) released by platelets and complement 
receptor 1 (CR1) present in plasma. After shearing, the amount of C1-INH released by 
platelets into the fluid phase was measured using a C1-INH EIA kit.  The results (shown 
in Figure 31) revealed that the amount of C1-INH released by platelets exposed to both 
low unidirectional (mean ± SD: 0.95±0.12, n=6) and high pulsatile shear (1.01±0.08, 
n=6) was significantly higher (P<0.05) compared to those exposed to normal shear 
(0.87±0.10, n=6).  
To investigate the role of CR1, platelets exposed to dynamic shear stress were 
incubated with human plasma and examined for their surface deposition of CR1 using a 
solid phase ELISA (Figure 32). Platelets exposed to low unidirectional shear 
(1.37±0.0.29, n=6) expressed an 18% increase in surface CR1 deposition compared to 
normal shear (1.16±0.16, n=4), while high magnitude pulsatile shear (1.42±0.43, n=8) 
induced a 23% increase. However, no statistical significance was detected. 
In summary, low magnitude pathological shear stress induced a significant 
increase in classical pathway complement activation compared to normal shear. 
However, the activation of complement inhibitors prevented the complement activation 
from proceeding to completion.  
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Figure 31. Amount of C1 inhibitor released by platelets when exposed to 
dynamic shear stress. OD values normalized to resting platelets and 
presented as Mean + SD. 
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Figure 32. Platelet surface CR1 expression after exposure to dynamic shear stress 
measured by solid phase ELISA. OD values normalized to resting platelets and 
presented as Mean + SD.  
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5.3.2 Platelet proteomic analysis 
 Platelets were stimulated with both biochemical (incubated with 20µM TRAP) 
and mechanical stimuli steady (1 and 3Pa) and pulsatile shear (normal, low and high 
magnitude pulsatile shear). Platelets were then lysed and platelet proteomes were 
analyzed using a SELDI mass spectrometer. Protein spectral patterns obtained in the low 
molecular weight range (m/z range: 2-20KDa) were analyzed and multiple protein peaks 
were detected. The intensity of protein peaks detected under TRAP-simulated platelets 
was compared to that of control (resting) platelets. Fourteen statistically distinct (P<0.05, 
n = 12) protein peaks were identified. The relative changes in peak intensity and 
associated P values are listed in Table 4. Figure 33 depicts the spectral profile 
constructed with the protein peaks that were significantly differentiated in TRAP 
activated platelets compared to resting platelets. In addition to changes in magnitude of 
protein peaks, the shape of spectral pattern of TRAP activated platelets was also altered 
compared to resting platelets.  
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Figure 33. Peptide/Protein spectrum profile of platelets activated with TRAP 
compared to control (resting platelets). The markers are representative of m/Z 
values that are significantly different (P<0.05) under TRAP activation compared 
to control, characterized by changes in normalized intensity at every m/Z value.  
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Table 4. The percent change in normalized intensity compared to resting platelets 
along with the corresponding  P values for each m/Z peak. 
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Similarly, SELDI TOF profiles of platelets exposed to both low and high constant 
shear stress (1 and 3Pa) were analyzed. No statistically significant difference in 
protein/peptide peaks was detected in platelets exposed to low constant shear (1 Pa) 
compared to resting platelets. However, platelets exposed to high magnitude constant 
shear stress (3 Pa) had three distinct protein peaks, at M/Z of 2241.04 (53% reduction), 
2441.18 (59% reduction) and 4981.34 (85% increase), which were statistically significant 
(P<0.05, n=8-12) compared to resting platelets (summarized in Table 5). A spectral 
profile compiling the significantly differentiated protein peaks, shown in Figure 34, 
indicated that constant shear stress only affected the magnitude of the protein peaks but 
did not alter the shape of the spectral profile. 
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Figure 34. Peptide/Protein spectrum profile (characterized by m/Z) of platelets 
exposed to 3Pa and1Pa constant shear when compared to control (resting 
platelets, n=8-12). The three peaks (marked with *) are specific m/Z values 
(2411, 2441, 4981) that are significantly different constant shear of 3Pa 
compared to resting control platelets.  
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Table 5. The percent change in normalized intensity compared to resting 
platelets along with the corresponding P values for each m/Z peak. 
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In addition, effects of dynamic shear stress on platelet proteomes were examined. 
Platelets exposed to both physiological and pathological shear stress revealed different 
spectral patterns (composed of significantly differentiated peaks) compared to resting 
platelets (Figure 35). Though the shape of spectral profile was similar between pulsatile 
shear and resting platelets at the lower end of spectrum (m/Z<7500), changes were 
observed between m/Z of 7500 and 10000. High magnitude pulsatile shear induced 
changes in the shape of the spectral profile compared to normal shear, while no change 
was observed under low magnitude pulsatile shear.  
In addition, at two particular m/Z, i.e., 2439.23 and 3274.88, statistically 
significant (P<0.05, n=8) difference was detected under pathological shear stress 
conditions, compared to normal shear. At m/Z = 2439, both low (49.46% reduction) and 
high magnitude (72.52% reduction) pulsatile shear induced a significant reduction 
(P<0.05) compared to normal shear; while at m/Z = 3274, high magnitude pulsatile shear 
(96.46% increase) induced a significant increase compared to normal shear. Table 6 
summarizes the percent change in normalized intensity along with the P values of low 
and high magnitude pulsatile shear compared to normal shear.  
 In summary, spectral profiles (of significantly differentiated proteins) in the low 
molecular weight region clearly indicated that platelets could sense the difference in 
shear stress patterns.   
Overall, platelet activation (i.e., CD62P expression) or thrombin generation might 
not be the responsive mechanisms platelets take in response to various dynamic shear 
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stress conditions. However, platelets could distinguish the different dynamic shear stress 
patterns, through complement activation, and changes in proteomic profiles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 35. Protein/peptide spectrum profile of platelets exposed to normal, low 
and high magnitude pulsatile shear compared to resting control platelets (n=8). 
The two peaks  (marked with *) are specific m/Z values (2439, 3274) that are 
significantly different under both low and high magnitude pulsatile shear 
compared to normal shear. The peak (marked with +) specific to m/Z value of 
8139 where all three pulsatile shear conditions induced a significant increase 
compared to control (resting platelets).  
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Table 6. The percent change in normalized intensity under low and high 
magnitude pulsatile shear compared to platelets exposed to normal shear along 
with the corresponding P values for each m/Z peak. 
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The results reported above summarized how EC and platelets responded to 
dynamic shear stress separately. The following section reported EC and platelet responses 
to dynamic shear stress when they were exposed to shear stress simultaneously. EC and 
platelet were exposed to only three different shear stress waveforms – normal (Figure 
14), low magnitude pulsatile (Figure 14) and platelet high magnitude pulsatile shear 
(Figure 15). The oscillatory shear waveform was not used, because in reality platelets are 
not exposed to oscillatory conditions, as shear is always against them.  
 
5.4 Effect of dynamic shear stress on EC – Platelet interaction 
The effect of dynamic shear stress on EC-platelet interaction was investigated by 
exposing platelets to all three dynamic shear stress waveforms in the presence of HCAEC 
using a cone-plate shearing system, or a parallel-plate flow chamber. After EC and 
platelets were exposed to dynamic shear stress together for 60 min, their cellular 
responses, including EC activation and inflammatory responses, platelet thrombogenicity, 
platelet complement activation and EC-platelet adhesion were measured. 
5.4.1 EC response to dynamic shear stress in the presence of platelets 
Shear induced EC activation in the presence of platelets was measured by EC 
surface ICAM-1 and TF expression using a solid phase ELISA. The results are presented 
as normalized O.D. values (to that of EC incubated with platelets and not exposed to 
shear) in Figure 36 and 37. Compared to normal shear, both pathological dynamic shear 
stress did not induce any significant changes in EC surface ICAM-1 or TF expression.  
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However, the presence of platelets affected EC surface ICAM-1 expression, 
compared to when EC were exposed to shear stress alone. Under low pulsatile shear, the 
presence of platelets led to a significant decrease in EC surface ICAM-1 expression (n=5; 
P<0.05, from 1.38±0.44 to 0.81±0.19, normalized O.D. value). Under elevated pulsatile 
shear stress, EC surface ICAM-1 expression increased slightly from 0.82±0.11 (n=5) to 
0.95±0.21 (n=5), but no statistical significance was detected. These results indicated that 
platelets could help to reduce EC activation level under pathological dynamic shear 
stress. Also, with the presence of platelets, EC were not able to distinguish the variation 
in dynamic shear stress patterns (different from when they were exposed to shear stress 
alone).  
Similar effect from platelets was observed with EC surface TF expression: with 
the presence of platelets, EC were not able to respond to the changes in dynamic shear 
stress patterns, by varying cell surface TF expression. In a similar experiment conducted 
in our lab, EC surface vWF expression was examined in the presence of platelets. No 
significant changes (data not shown) in surface vWF expression was detected under all 
three dynamics shear stress conditions.  
In addition, EC ICAM-1 mRNA expression was measured after 60 min coupled 
shearing.  The relative mRNA expression measured (shown in Figure 38) revealed that 
both the low magnitude unidirectional and high magnitude pulsatile shear induced a 
significant reduction in ICAM-1 mRNA expression compared to normal shear. Compared 
to EC that were exposed to dynamic shear stress alone, the presence of platelets led to  a 
significant reduction in EC ICAM-1 mRNA expression (normal: 0.99±0.05, low: 
0.80±0.06, high: 0.56±0.14; n=3).  
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 To determine the activity of EC in the presence of platelets, the cells were 
exposed to normal shear and the supernatant was assayed to measure the amount of nitric 
oxide (NO) generated using a commercially available kit (Cayman Chemicals, Ann 
Arbor, MI). The results indicated that EC exposed to shear stress with and without the 
presence of platelets produced similar levels of NO, which was higher compared to EC 
that was not exposed to shear stress.  
In summary, the presence of platelets affected EC responses to dynamic shear 
stress in terms of ICAM-1 and TF expression. The effects took place in two ways: first, 
the presence of platelets decreased EC activation under pathological shear stress; second, 
with the presence of platelets, EC lost their sensitivity to different dynamic shear stresses. 
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Figure 36. Normalized EC surface ICAM-1 expression after dynamic shear 
exposure in the presence of platelets using solid phase ELISA. No statistical 
significance was detected (n=5). Data presented as Mean + SD. 
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Figure 37. Normalized EC surface TF expression after dynamic shear exposure in 
the presence of platelets using solid phase ELISA. No statistical significance was 
detected (n=5). Data presented as Mean + SD. 
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Figure 38. Normalized EC ICAM-1 mRNA expression after dynamic shear 
exposure in the presence of platelets using RT-PCR. Data presented as Mean + SD 
(n=5). 
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5.4.2 Platelet responses to dynamic shear stress with the presence of EC 
In a study conducted in our lab, platelet activation was measured by CD62P 
expression when sheared in the presence of EC
100
. The results indicated that platelet 
gained sensitivity to dynamic shear stress exposure, and platelet surface CD62P 
expression was elevated significantly under high magnitude pulsatile shear stress,  
compared to normal shear. After platelets were exposed to dynamic shear stress with the 
presence of EC, thrombin generation was measured. The results demonstrated a 
significant increase in thrombin generation under low magnitude and high magnitude 
pulsatile shear compared to normal shear (Figure 39).  
In addition, to assess platelet complement activation in response to dynamic shear 
stress with the presence of EC, platelet surface C1q deposition was measured using flow 
cytometry. No significant changes in C1q deposition were detected between all three 
dynamic shear stress conditions. The normalized all mean fluorescence values 
quantifying C1q deposition is summarized in Table 6. The all mean fluorescence values 
are normalized to the same day resting platelets. Compared to data reported in Table 3, 
with the presence of EC, the low magnitude shear induced increase in C1q deposition 
disappeared.   
In summary, EC altered platelet responses to dynamic shear stress. When platelets 
were exposed to dynamic shear stress alone, they did not respond to various shear stress 
patterns differently through cell activation or thrombin generation, but through 
complement activation. With the presence of EC, platelet complement activation was 
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completely inhibited from initiation, while platelets responded to pathological shear 
stress through cell activation and increased thrombin generation.  
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Figure 39. Platelet activation response measured as the rate of thrombin 
generation, at the end of 60 min exposure to various dynamic shear stress in the 
presence of endothelial cells. Data is presented as Mean + SD (n=6-7).  
Table 7. Normalized all mean fluorescence value of platelets exposed to normal, 
Low magnitude unidirectional and high magnitude pulsatile shear in the 
presence of EC. 
120 
 
5.4.3 Platelet adhesion to EC monolayer under dynamic shear stress 
 After shearing simultaneously in a cone and plate shearing device, the amount of 
platelets or platelet microparticles adhesion to EC was measured using 
immunofluorescence microscopy. Actin fibers from EC and platelet cytoskeleton were 
detected using phalloidin (FITC/green), platelet GPIbα was detected by TRITC-
conjugated mouse anti human GPIb antibody (red), and EC nuclei were detected using 
DAPI (blue). Nonspecific antibody binding was detected by incubating the cells with a 
MOPC-FITC/TRITC antibody (Figure 40). High magnification images (100X, Figure 
40A) were obtained to characterize the deposited particles, based on their size. The 
average size of the deposited particles was found to be 2-3µm, indicating that they were 
platelets. The ratio of platelet deposited area to the total image area was estimated and 
presented in Figure 41. Both low (Mean±SD: 17.68±3.81, n=4) and high (14.71±3.94, 
n=4) magnitude pulsatile shear induced a significant increase in platelet deposition 
compared to normal shear (9.38±4.74, n=4, P<0.05).  
 Alternatively, platelet adhesion to EC was measured using R-PE conjugated 
PECAM-1 antibody, FITC conjugated CD42b antibody and DAPI. Typical results are 
shown in Figure 42. Platelet adhesion was quantified by comparing the number of 
adhered platelets to the total number of EC (the ratio was calculated). Cell counting was 
conducted independently by two different observers.  Similar to the experiments using 
phalloidin, both low (Mean±SD: 34.63±12.44, n=4) and high (21.4±7.01, n=5) magnitude 
pulsatile shear induced a significant (P<0.05) increase in platelet deposition compared to 
normal shear (10.6±3.73, n=5).   
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To determine if the observed platelet adhesion to EC monolayer was through 
GPIb and/or GPIIb/IIIa,  platelets were incubated with GPIIb and GPIbα blockers 
before co-shearing with EC. Representative images of platelet deposition with GPIbα and 
GPIIb blocked are presented in Figure 43 (A-F). The results demonstrated that blocking 
either GPIbα or GPIIb/IIIa did not induce any noticeable changes in platelet adhesion to 
EC.  
 As the cone-plate device did not provide a physiologically realistic EC-platelet 
interaction environment, similar experiments were conducted in a parallel-plate flow 
chamber, where platelets and EC were exposed to different dynamic shear stress at the 
same flow rate.  Post shearing (60 min), the cells were fixed and stained with TRITC 
conjugated PECAM-1 (red) and DAPI (blue, EC nucleus) antibody. Figure 44 depicts the 
representative images of platelet adhesion to EC. In general, platelet adhesion to EC 
monolayer decreased compared to that observed in cone-plate shearing experiments. 
Platelet adhesion quantified by counting (as described above) indicated that the low 
pulsatile shear stress (Mean±SD: 5.33±2.65, n=4) induced a significant increase (P<0.05) 
in platelet deposition compared to normal shear (1.21±0.29, n=4), while no difference 
was detected under high magnitude pulsatile shear (0.89±0.16, n=4).   
Since the cone and plate shearing device was a closed system, more platelet 
adhesion occurred, compared to the parallel plate flow chamber.  Pathological shear 
stress (high and low) could affect platelet adhesion to EC. Particularly, low pulsatile 
shear stress could enhance platelet-EC adhesion. Also, platelet adhesion observed here 
was not primarily mediated through platelet membrane receptors GPIbα or GPIIb/IIIa. 
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Figure 40. Representative fluorescence microscopy images indicating the amount of 
platelet deposition on EC after coupled shear exposure. The cells were stained for 
actin. (A) 100X magnification images revealing platelet adhesion, (B-D) Dynamic 
shear stress waveforms, (E) MOPC staining. Scale (A) 10µm, (B-E) 50µm.  
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Figure 41. Area covered by platelets deposited on EC was quantified, and the 
ratio of platelet deposited area to the total area of the image is presented above.  
The bars are representative of Mean + SD (n=4). 
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Figure 42. Representative fluorescence microscopy images (A-C 20X, D-F 100X) 
indicating the amount of platelet deposition on EC after coupled shear exposure by 
using PECAM-1 as marker protein. Scale 10 µm.   
125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 43. Ratio of total number of platelets adhered to the number of  EC after 
exposure to pulsatile shear stress in a cone-plate shearing device. The bars of 
representative of Mean + SD (n=4-5). 
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Figure 44. Platelet GPIbα (A-C) and GPIIb/IIIa (D-F) were blocked and sheared in 
the presence of EC. Representative fluorescence microscopy images (100X) 
indicating platelet deposition on EC after coupled shear exposure by using 
PECAM-1 as marker protein. Scale 10 µm.   
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Figure 45. Representative fluorescence microscopy images (20X) indicating 
platelet deposition on EC after coupled shear exposure in a parallel plate flow 
chamber. The cells were stained for EC/Platelet PECAM-1 (red) and EC nucleus 
(blue). Scale 50 µm.   
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Figure 46. Ratio of total number of platelets adhered to the number of  EC, 
after exposure to pulsatile shear stress in a flow chamber. The bars are 
representative of Mean + SD (n=4). 
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CHAPTER VI 
 
 
DISCUSSION 
 
Blood flow induced shear stress plays a critical role in the localization and 
pathogenesis of atherosclerosis. The anatomical location and complex geometry of 
coronary arteries create highly complex blood flow conditions. The characteristics of 
such disturbed blood flow include altered shear stress, which help the localization and 
growth of atherosclerotic lesions inside the coronary arteries.  
Flow can affect the normal functions of vascular wall endothelial cells (EC) and 
circulating platelets greatly.  The major focus of this study was to use numerical methods 
to estimate the shear environment inside the left coronary artery (LCA) under normal and 
disease conditions, and to investigate the effect of physiologically relevant dynamic shear 
stress on EC and platelet activities.  
6.1 Research Design  
Through four specific aims, the current study aimed to investigate how 
physiologically relevant dynamic shear stress affects EC and platelet activities.  
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The purpose of SA1 was to develop a 3D numerical model of the human left 
coronary artery, and utilize computational fluid dynamics tools to estimate the shear 
stress environment under normal and disease conditions. The estimated shear stress 
history on both endothelial cells (vessel wall) and platelets (particles in discrete phase) 
was used in the in vitro studies (SA2, 3 and 4) to mimic in vivo stress conditions. 
Through SA2, we wanted to investigate how physiologically relevant dynamic shear 
stress affects endothelial cell (EC) responses, especially those pertaining to the 
pathogenesis of CHD and related thrombosis. In parallel, through SA3, we aimed to 
investigate how physiologically relevant dynamic shear stress affects platelet activation 
and inflammatory responses. In SA4, a more complex coupled shearing system was 
developed to expose EC and platelets to dynamic shear stress simultaneously, and the 
role of EC-platelet interaction on cell responses to shear stress was investigated. 
6.2 CFD analysis of coronary flow 
6.2.1 Coronary flow geometry, model and assumptions  
In this study, a physiologically realistic 3D human left coronary artery (LCA) 
model was reconstructed from arteriography data (Figure 8)
91;92
 and fluid flow through 
the vessel was analyzed under normal and disease conditions (30%, 60% and 80%). A 
stenosis was created by adding an asymmetric flow constriction inside the LAD branch 
near the bifurcation. Previous studies have modeled stenosis as both asymmetric and 
axisymmetric constrictions
24
. Near an asymmetric stenosis, flow separates at the peak of 
the stenosis throat, while the core flow is skewed towards the opposite vessel wall, 
increasing the wall shear stress. At an axisymmetric stenosis, with a fully developed 
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upstream flow condition, flow separates just before the apex of the stenosis and forms 
symmetric recirculation zones opposite to each other. The majority of the atherosclerotic 
plaques found in vivo are asymmetric and hence our disease condition was modeled 
asymmetrically. 
Coronary blood flow is opposite to cardiac output, with highest flow rate 
occurring in diastole. The pulsatile inlet flow used in this study was calculated based on 
cardiac output, with an average coronary inlet flow rate of 200mL/min.  To avoid inlet 
effects, a fully developed inlet flow profile was imposed at the inlet boundary. Also, to 
avoid any exit effects, the outlet boundary was set at atmospheric pressure. In addition, 
the regions of interest (near stenosis throat) were at least 7 diameters away from the 
outlet. Based on an earlier work published by our lab, a laminar solver was used for 
normal, 30%, and 60% stenosis condition, while a low Reynolds k-ω solver was used for 
80% stenosis condition with a minimal 3% turbulent intensity
99
. The CFD analysis 
yielded a comprehensive flow and shear stress map inside LCA.   
One of the limitations of this CFD model is the assumption of a rigid non-porous 
vessel wall. The blood vessel wall is viscoelastic. Stretching of the vessel wall could have 
a major impact on the amount of cyclic circumferential/axial strain imposed on the 
endothelium of the vessel wall.  In addition, partially embedded in the heart muscles, 
coronary vessels undergo continuous dynamic motion along with the myocardium. Due 
to the requirement of a complex fluid – structure interaction model, both the vessel wall 
viscoelasticity (stretching) and the bending motion of the coronary vessels was not 
modeled in this study.    
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Santamarina et al. demonstrated in their study that considering the dynamic 
motion of coronary vessels (cardiac base frequency of 1 Hz) induced only about 6% 
change in wall shear rate estimation
101
. Further, an improved coronary flow model was 
recently built in our lab to include the dynamic motion of the vessel. The results from this 
model indicated the wall motion induced a slight reduction in the magnitude of peak 
shear stress, but did not have any major effects on flow parameters. Hence, we expect 
that these two assumptions should not significantly affect our shear stress estimation. 
6.2.2 EC wall shear stress distribution 
 According to our simulation, flow separated before the bifurcation and skewed 
towards the inner wall in the LAD, resulting in a high shear stress region. On the opposite 
side in the LAD, regions of oscillatory flow developed.  Under normal conditions, the 
WSS varied between 0.1-1Pa (in one cardiac cycle), similar to the levels observed by 
Perktold et al. in their study
21
.  
Under stenosis, as its severity progressed, a region characterized by high fluid 
velocity and increased shear stress formed near the center point of the stenosis throat due 
to the sudden narrowing of the blood vessel. WSS peaked at about 14.21Pa with a 80% 
stenosis. This value was very close to that reported by  Deplano et al.; in their study, the 
peak shear stress at the stenosis throat (75%) inside a coronary artery was found to be 
12Pa, through both experimental and numerical methods
102
. A number of other previous 
studies that employed simplified LAD geometry (2D or 3D) estimated much higher shear 
stress, ranging from 125Pa to 900Pa. The huge variation in WSS estimation is due to the 
simplicity of geometry and flow assumptions. It was reported that endothelial cells would 
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be damaged at shear stress of about 40Pa and would be stripped off at 100 Pa
13
, which 
suggested that the high WSS estimated using simplified CFD models is not 
physiologically accurate.  
Immediately past the stenosis throat, flow separated, forming a recirculation zone 
characterized by low shear stress (between 0.01 to 0.5Pa in one cardiac cycle). The size 
of the recirculation zone was dependent on the severity of the stenosis. As stenosis 
severity increased, the size of the recirculation zone increased. Downstream of the 
stenosis, the flow reattached to the vessel wall and the shear stress returned to normal 
levels.  The spatially and temporally localized high and low shear stress is one of the 
major factors contributing towards the pathogenesis of CHD. Points of interest inside the 
flow domain were isolated and the WSS history (over one cardiac cycle) was exported to 
be used in in vitro studies to investigate the effect of dynamic shear stress on EC and 
platelets.  
6.2.3 Platelet shear stress distribution 
Platelets are sensitive to both shear stress magnitude and the duration of shear 
exposure, as highlighted by recent studies
2;3
. In the present study, 1000 platelet 
simulating particles were released at the inlet of the left coronary artery and their 
trajectories were estimated using a discrete phase model (typical trajectories shown in 
Figure 19). Based on their trajectory, the hemodynamic shear stress history (both shear 
stress magnitude and shear exposure duration were considered) of each platelet as it 
traveled through the left coronary artery was estimated. This platelet seeding density 
(1000) was chosen so as to estimate maximum possible trajectories while maintaining an 
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optimal computational load. As the discrete phase, platelets were treated as virtual 
particles, which can interact with the fluid phase and affect flow parameters. The solver 
was able to estimate forces applied to platelets imparted by flow, including the drag 
force. At the end of each time step, the solver calculated the instantaneous velocity, 
acceleration and displacement of platelets. On the other hand, platelet induced changes in 
mass, momentum and energy of the fluid phase was also estimated.  
In this study, platelets were modeled as solid particles. But in vivo, platelets are 
viscoelastic and they may undergo significant deformation resulting from sudden changes 
in shear stress, especially near a stenosis. This could potentially affect platelet 
biochemical responses
93
. However, to model platelet deformation in response to dynamic 
blood flow, a structural solver accounting for platelet membrane properties (stiffness, 
yield stress etc.) needs to be coupled to the fluid solver. At every time step, for each 
platelet, flow induced surface forces estimated by the fluid solver needs to be transported 
to the structural solver and used to estimate platelet deformation. Changes in platelets 
would need to be reported back to the fluid solver to update the flow parameters, as the 
fluid phase and the particle phase needed to exchange mass, momentum and energy 
continuously.  Furthermore, the difference in length scale (mm to μm scale) between the 
flow domain (which is the source for deformation force) and the particulate phase (where 
the actual deformation happens) would present a major difficulty to the computational 
effort. Therefore, in the current model, platelet deformation was not considered. Also, in 
this model, platelets were modeled as biochemically inert particles, i.e., platelet 
biochemical responses to flow were not considered.  In this study, three typical platelet 
trajectories were sampled and their corresponding shear stress history was presented in 
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Figure 15. The shear waveforms were estimated from trajectories that were close to the 
vessel wall. This is due to the fact that in larger vessels platelets tend to move close to the 
vessel wall rather than to the center of the flow
103
. Also, the shear gradients are greater 
near the vessel wall. Therefore, platelets travelling in this region have a higher chance to 
become activated and adhere to the vascular wall.  
The normal shear waveform was chosen to represent platelets that travelled 
through the LAD under normal conditions, and the magnitude of shear exposure varied 
between 0.1-1Pa. In general, under physiological conditions, platelets traveling through a 
normal vessel are exposed to a shear stress range of 0.7-1.6Pa
104
. The high-magnitude 
pulsatile shear stress waveform was used to simulate shear stress history of platelets that 
travelled through the stenosis close to the vessel wall and momentarily experienced high 
shear. We assumed that the same platelets would pass through the same stenosis once 
every 90 sec. Platelets that were trapped inside the recirculation zone downstream of the 
stenosis experienced low magnitude shear stress. These platelets had higher collision 
frequency and longer residence time, which could potentially increase their activation 
potential
105
.  
6.3 Endothelial cell response under dynamic shear stress  
ECs lining the innermost layer of blood vessels are directly exposed to blood flow 
induced shear stress and their functions are susceptible to regulation by shear stress. For 
this study, a cone and plate shearing device (Figure 11) was programmed with WSS 
history obtained from our numerical simulation. Confluent monolayers of human 
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coronary artery endothelial cells (HCAEC) were exposed to these shear stress waveforms 
and their activation/inflammation responses were monitored.  
One of the major activation markers investigated in this study was intercellular 
adhesion molecule 1 (ICAM-1). ICAM-1 has been extensively studied as it plays a major 
role in binding and sub-endothelial migration of leukocytes in the initial stages of 
atherosclerosis. It also acts a receptor for platelet adhesion through fibrinogen. In this 
study, EC were exposed to four different dynamic shear stress waveforms and ICAM-1 
levels were examined at surface, total protein and mRNA levels (Figure 20). Compared 
to normal shear, EC exposed to low magnitude unidirectional shear had a slight increase 
(not statistically significant) in surface ICAM-1 expression, a significant increase in 
ICAM-1 total protein expression, but no significant changes at mRNA level. Low 
oscillatory shear stress induced a significant increase in EC total ICAM-1 expression, but 
did not lead to any changes on the cell surface or at the mRNA level. This is similar to 
that observed with the low magnitude unidirectional pulsatile shear stress. The 
inconsistencies between surface ICAM-1 expression and total ICAM-1 expression could 
be potentially due to the difference in shear exposure time.  In studies conducted by 
Morigi et al. and Nagel et al,  it was observed that EC surface ICAM-1 expression 
increased linearly as a function of shear exposure time
38;40
. Both studies also reported 
significant increase in ICAM-1 mRNA expression after 2 hours of shear expsoure
38
. By 
increasing shear exposure time, we expect to see significant changes in ICAM-1 
expression, on EC surface or at mRNA level, matching the trend we saw with the total 
protein expression.  
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In addition to EC activation, shear stress induced EC injury/inflammation was 
examined by measuring tissue factor (TF) and thrombomodulin (TM) expression at the 
surface protein, total protein and mRNA level. TF plays a major role in triggering the 
coagulation cascade under both physiological (maintaining hemostasis) and pathological 
(thrombosis) conditions. EC were sensitive to different dynamic shear stress waveforms 
and produced varying levels of TF. Compared to normal shear, low magnitude 
unidirectional shear led to an elevated (not statistically significant) surface TF expression, 
which could increase the coagulation potential inside the recirculation zone. However, 
the total protein and mRNA levels was lower compared to normal shear. In contrast, low 
magnitude bidirectional shear induced a slight reduction in TF protein expression 
(surface and total) but had an increased TF mRNA expression. It is not clear why TF 
expression at protein level and at mRNA level was not consistent. It could be due to the 
difference in shear exposure time, or some posttranscriptional regulations
106
. Elevated 
pulsatile shear stress did not lead to any change in TF expression at protein level (surface 
and total), but induced a significant reduction in mRNA expression. So, in general, 
pathological dynamic shear stress could reduce EC TF expression, which may indicate 
the activation of certain inhibitory mechanism that can prevent both EC activation and 
inflammation.  
Thrombomodulin (TM), produced by EC, is an athero-protective protein that can 
inhibit thrombin. Surface ELISA and Western blot experiments revealed a significant 
reduction in TM expression on EC exposed to pathological shear stress. RT-PCR results 
indicated a downregulation in TM mRNA expression under low magnitude unidirectional 
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shear and high magnitude pulsatile shear compared to normal shear, though not 
statistically significant.  
 Von Willebrand Factor (vWF) provides a major binding site on EC surface 
(receptor) for platelet surface GPIbα (ligand), playing a key role in EC-platelet adhesion. 
EC produce ultra large molecular weight vWF and store them in Weibel-Pallade bodies. 
Compared to normal shear, both low and high magnitude pulsatile shear did not induce 
any changes in vWF at protein level (surface and total). This is consistent with a report 
by Galbusera et al., that shear stress between 0.1-1.2Pa would lead to no changes in EC 
vWF expression (surface protein and mRNA). Interestingly, in present study, 
recirculation shear led to slight upregulation in surface vWF expression along with an 
elevated mRNA expression measured using RT-PCR. This might indicate that the EC 
were able to sense low magnitude pulsatile shear and produce more vWF. An elevated 
vWF concentration inside the recirculation zone, along with the increased platelet 
population trapped inside this zone could potentially promote platelet adhesion to EC and 
ultimately lead to thrombus formation. However, changes from long duration shear 
exposure need to be investigated.  
6.4 Platelet response to dynamic shear stress  
 Recent studies have highlighted the effect of shear stress magnitude and duration 
on platelet activities
2;3
. Since in vivo flow conditions are dynamic, it is important to 
investigate the role of physiologically relevant dynamic shear stress on platelet activation 
and other related responses. In the present study, platelets were tracked as they travelled 
through the left coronary artery (especially the left anterior descending artery) and their 
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shear stress history along their path was calculated. As mentioned above, three specific 
shear stress waveforms were used; they represent shear stress history of platelets that 
travelled through a normal artery, a 60% stenosed artery, and were trapped inside the 
recirculation zone downstream of the stenosis throat.  
Previously, we reported that both low magnitude pulsatile shear and high 
magnitude pulsatile shear did not lead to platelet activation in terms of P-selectin 
expression
100
, or induce significant changes in platelet thrombogenicity, compared to 
normal pulsatile shear
4
. In this study, we furthered our previous investigation by 
examining platelet associated complement activation and proteomic changes under 
dynamic shear stress.  
6.4.1 Platelet complement activation 
Platelets were exposed to all three different shear stress waveforms in a cone-plate 
shearing device, following which, the amount of complement protein deposited (C1q, 
C4d, iC3b and sC5b-9) was measured.  The results indicated that platelets stimulated 
with low magnitude pulsatile shear had an elevated C1q deposition compared to normal 
shear (Figure 28), even though platelets were not activated. Further, high magnitude 
pulsatile shear did not induce any noticeable change in C1q deposition compared to 
normal shear. The finding matched a report by Peerschke et al.
76
, that resting platelets 
support complement activation. However, following C1q activation, no significant 
changes in the subsequent complement proteins were detected. This prompted the 
investigation of the complement regulatory/inhibitory mechanism. C1-inhibitor could 
completely inhibit the progression of complement classical pathway cascade irreversibly. 
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Platelets exposed to both pathological shear (low and high) had a significantly increased 
expression of C1-inhibitor (Figure 31) compared to normal shear.  
Complement receptor 1 (CR1) can inhibit complement activation by cleaving C3b 
and C5b. Our results showed that both pathological shear stress induced noticeable CR1 
expression compared to normal shear stress, even though no statistical significance was 
detected (Figure 32).  
These results demonstrated that even though pathological pulsatile shear stress 
was not able to trigger platelet activation, platelets were able to sense the difference in 
flow patterns. By releasing increased amount of C1-inhibitor, platelets stopped 
complement activation at the very first stage, preventing the production of anaphylatoxins 
C4a, C3a and C5a, as well as the membrane attack complex (MAC), which could 
potentially cause platelet activation, thrombosis and cell death.  Also, platelets exposed to 
low pulsatile shear stress had a higher chance for C1q activation, it may suggest that the 
low pulsatile shear found inside recirculation zones could potentially be more 
atherogenic. 
6.4.2 Platelet proteomics 
 In addition, pulsatile shear stress induced changes in the platelet proteome were 
examined using the SELDI-TOF technique.  Yin et al. reported that platelets activated by 
TRAP (10 µM) or ADP (20 µM) revealed 7 distinct protein peaks that were significantly 
different compared to resting platelets
80
. However, platelets that were exposed to a steady 
shear (1.8Pa for 5min) revealed no distinct protein peaks compared to resting platelets. 
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These results demonstrated that SELDI-TOF might be an effective method to study 
platelet responses to different agonists.  
 In this study, platelets were activated by both constant (1 and 3 Pa) and pulsatile 
shear stress (normal, low magnitude unidirectional and high magnitude pulsatile shear). 
In addition, platelets treated with TRAP (10μM) were used as the positive control. 
Proteomic analysis of these samples was conducted using SELDI with a special focus on 
the low molecular weight range of the spectrum (M/Z 2,000 to 15,000). TRAP-treated 
platelet samples showed nine distinct protein peaks that were significantly different from 
resting platelets (Figure 33 and Table 4). Similar to the early study conducted by Yin et 
al., no distinct peaks were identified under low steady shear stress (1Pa); however, under 
high shear stress (3Pa) three distinct peaks were detected compared to resting platelets 
(Figure 34). Interestingly, the spectral profiles indicated that TRAP activated platelets 
(Figure 33) had a significantly different profile (both shape and magnitude) compared to 
those activated by constant shear (Figure 34). This indicates that platelets respond 
differently to biochemical and biomechanical stimuli; SELDI, or platelet proteomic 
analysis, may be useful for detection of agonist specific biomarkers. When platelets were 
treated with the three dynamic shear stresses, 8 new peaks were detected,  which were 
different from the peaks detected from TRAP or constant shear stress treated platelets  
(Figure 35). Among the three dynamic shear stresses, both low and high pulsatile shear 
stress induced a significant reduction in peak intensity at M/Z of 2439.23; while high 
magnitude elevated pulsatile shear stress induced a significant increase in peak intensity 
at M/Z of 3274, compared to normal shear. Also, the differentiated protein profile (shape 
and magnitude) induced by high magnitude pulsatile shear stress was different from that 
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induced by normal shear stress. These results indicate that platelets were able to sense the 
difference in dynamic shear stress waveforms, by expressing different proteome patterns. 
In a parallel work conducted in our lab, platelets were exposed those three dynamic shear 
stress waveforms and platelet activation was measured by cell surface CD62P and CD41a 
expression using flow cytometry. No difference in CD62P and CD41a expression was 
detected, indicating that platelet surface CD62P and CD41 could not be used as activation 
markers to distinguish the difference between normal, low and elevated pulsatile shear 
stress
100
. Together, these results suggested platelet proteomic profiles (especially at the 
low molecular weight range) could be potentially used to detect subtle differences in 
dynamic shear stress under various flow conditions.  
Among all the distinguished peaks detected by SELDI, 2 protein peaks were of 
special interest to us. One peak occurred at M/Z of 8,139. The peak intensity decreased 
significantly upon TRAP treatment (43.28% decrease) but increased significantly under 
dynamic shear stress activation (Normal - 255%, Low magnitude unidirectional - 362%, 
High magnitude pulsatile - 199%), compared to resting platelets. No significant change 
was detected under constant shear stress (1Pa – 11.6% decrease, 3Pa – 0.003% 
reduction). The other peak occurred at M/Z of 4,975. All treatment induced changes at 
this peak compared to resting platelets: TRAP induced a 152.92% increase, constant 
shear stress at 3 Pa induced a 84.55% increase, while all three dynamic shear stress 
waveforms (normal - 26%, Low magnitude unidirectional - 37%, high magnitude 
pulsatile - 61%) induced a reduction compared to resting platelets.  
Platelet lysate samples were also analyzed using a liquid chromatography mass 
spectrometry (Orbitrap) technique, to identify platelet-associated proteins that could be 
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used to distinguish different stimuli. This could potentially result in the identification of 
particular protein biomarkers for platelet activation. Data (3 biological replicates and 4 
technical replicates) obtained from Orbitrap MS/MS analysis estimated that the protein 
peak at M/Z of 4,975 could possibly be Thymosin Beta - 4 (5kDa), an actin monomer 
sequestering protein; and the protein peak occurring at M/Z of 8,139 could possibly be 
Platelet Factor 4 (7.8kDa). Thymosin beta-4 has recently been implicated in regulating 
EC functions
107
, especially in proliferation and angiogenesis regulation
108
, while Platelet 
Factor 4 is involved in angiogenic responses during tumor metastasis conditions
109
. Since 
Orbitrap MS/MS was not able to provide very accurate information on protein ID at low 
molecular weight (<10,000 Da), no more differentiated proteins were detected by both 
SELDI and Orbitrap techniques.  Further experiments are required to confirm the protein 
identification and to verify their role in shear induced platelet activation. 
6.5 Endothelial cell – platelet interaction 
Under in vivo conditions, EC are constantly exposed to dynamic shear stress in 
the presence of platelets. The complex interaction between EC and platelets play a central 
role in hemostasis, thrombosis and atherosclerosis. In order to investigate how EC-
platelet interaction would affect EC and platelet cellular responses to dynamic shear 
stress, a coupled shearing system (washed platelets placed on confluent monolayer of EC 
and exposed to shear stress) was employed.  
Our results showed that with the presence of platelets, pathological shear stress 
(low and high) failed to induce any changes in EC surface ICAM-1 expression, which 
was different from what was observed when EC were exposed to dynamic shear stress 
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alone. Further, similar amount of NO generation by EC was observed when the platelets 
were present indicating that the EC activity was intact. This result strongly suggested an 
inhibitory role of platelets on EC activation. This inhibitory effect from platelets was 
further investigated at mRNA level. RT-PCR demonstrated that with the presence of 
platelets, there was a significant reduction in ICAM-1 mRNA expression under 
pathological shear stress, compared to normal shear. In addition, when sheared alone, low 
magnitude pulsatile shear stress induced a slight increase (not significant) in EC TF 
expression. However, with the presence of platelets, no changes in EC surface TF 
expression was detected under both low and high pathological shear stress conditions.  
Further, in a parallel experiment conducted in our lab, no significant change in EC 
surface vWF was detected. Hence, in the presence of platelets, EC lost their sensitivity to 
dynamic shear stress waveforms, and failed to express any changes in ICAM-1, TF and 
vWF expression.  
The protective interaction between platelets and EC could take place in two ways: 
1) through soluble factors released by platelets, such as substances from platelet  
granules, dense bodies and platelet microparticles; 2) through direct physical contact 
between platelets and EC, such as surface adhesion molecules or receptors; or 3) a 
combination of both mechanisms.  
The major biochemical factors released by platelets include ADP, thrombin, 
platelet derived growth factor (PDGF) and fibrinogen. Studies conducted in the past 
indicated that most of these factors induce EC activation
110
. In a study conducted by Hess 
et al., ADP was found to modulate eNOS (endothelial nitric oxide synthase) expression 
and cell migration in EC
111
. The presence of fibrinogen was found to synergistically 
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enhance interleukin-8 induced NO (nitric oxide) production
112
, and PDGF was found to 
modulate endothelial proliferation and angiogenesis
113
. In addition, platelet 
microparticles released by shear stress  were found to promote EC activation (cytokine 
production and adhesion molecule expression)
114
. Based on the above literature evidence, 
it is highly unlikely that one of the platelet releasate was responsible for inhibition of EC 
activation. On the other hand, direct interaction of platelets with EC could potentially be 
responsible for inhibition of EC activation.  
Platelet adhesion to EC was measured using immunofluorescence microscopy. 
The results indicated that more platelets deposited on EC monolayer under pathological 
shear stress (high and low) conditions. By analyzing higher magnification images, the 
deposited particles were found to be 2-3µm in diameter, indicating it was not platelet 
microparticles, but platelets, adhered to EC monolayer. Further, control experiments were 
conducted to test the effect of washing on platelet adhesion. The results indicated that 
there was no change in amount of platelet adhesion between washing and not washing the 
cells after shearing. The key platelet membrane receptors that are responsible for platelet 
adhesion to EC are GPIbα and GPIIb/IIIa. vWF, expressed on EC surface, acts as a key 
ligand for these receptors. EC surface vWF was abundant
115
. Results obtained from this 
study demonstrated that EC surface vWF expression was not affected by dynamic shear 
stress. However, free vWF in the fluid phase (released by EC and platelets) increased 
after EC and platelets were simultaneously exposed to low magnitude pulsatile shear 
stress.  
When platelets were exposed to dynamic shear stress alone, cell surface GPIbα 
and GPIIb/IIIa expression was not affected by shear stress patterns. While in the coupled 
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shearing experiments, with the presence of EC, the low magnitude pathological shear 
stress resulted in an increase in platelet surface GPIbα expression, while no change in 
GPIIb/IIIa expression was noticed
100
. Increased soluble vWF and GPIbα indicated an 
increased potential in platelet adhesion to EC. To determine if these receptors (GPIbα, 
GPIIb/IIIa and vWF) were responsible for platelet-EC adhesion we observed in the co-
shearing studies, GPIb was blocked by anti-human GPIbα blocking antibody, and GPIIb 
was blocked by tirofiban. The results showed that blocking both GPIbα and GPIIb/IIIa 
did not cause any change in platelet adhesion to EC monolayer. However, the efficiency 
of both the blocking agents (against GPIbα and GPIIb/IIIa) on platelets was not verified 
in this study. This suggested platelet adhesion to EC under dynamic shear stress 
conditions was through other proteins. Some of the other potential target EC surface 
adhesion molecules that support platelet binding includes PECAM-1, P-selectin
116
 and 
ICAM-1
83
. Further studies are needed to evaluate their expression and adhesion potential 
under dynamic shear stress conditions.  
The major limitation to the coupled shearing study was the use of the cone and 
plate shearing device. The flow pattern in the cone and plate device did not provide a 
physiologically realistic shear environment for EC and platelets (it was a closed system). 
Therefore, a parallel plate flow chamber was used alternatively. The adhesion 
experiments indicated a slight increase in platelet adhesion to EC monolayer under both 
low and high pulsatile shear stress, compared to normal shear stress, which was similar to 
that found using a cone and plate device.  
In general, under all three dynamic shear stress conditions, the overall platelet 
binding was lower in the parallel plate flow chamber, compared to that observed with the 
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cone and plate shearing device. This is primarily due to the fact that the cone and plate 
shearing device was a closed system, where platelets were continuously exposed to EC. 
Platelet-EC interaction time in the cone and plate shearing device was much longer than 
that in the flow chamber. The other major limitation in using the cone and plate shearing 
device for EC-platelet interaction was that substances released by both EC and platelets 
were accumulated within the same environment over time, which could possibly lead us 
to overestimate the effect from shear stress.  
6.6 Proposed Models 
6.6.1 Thrombus formation mechanism 
Based on these observations and findings, a possible mechanism for platelet 
activation and thrombus formation is presented in Figure 47. EC in the recirculation zone 
are exposed to pathological low shear stress, which could enhance EC surface ICAM-1 
and vWF expression. Platelets (quiescent or activated) could be trapped inside a 
recirculation zone. GPIb is always available on platelet surface, which would assist 
platelets adhere to the blood vessel wall (or EC). In addition, platelets also have abundant 
GPIIb/IIIa on their cell surface, which can assist firm adhesion to endothelium after the 
initial binding through GPIb and vWF. GPIIb/IIIa binding to the endothelium can occur 
through either, (1) GPIIb/IIIa – fibrinogen – ICAM-1 (more probable adhesion binding 
under low shear) or (2) GPIIb/IIIa – vWF (more probable under high shear) binding. 
Platelet binding to EC is also facilitated by the low shear stress presented in this region, 
which produces less bond breakage force and longer rolling time.  
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After the initial binding between GPIbα and vWF, through intercellular signaling 
cascades, platelet membrane GPIIb/IIIa molecules become activated. Through fibrinogen, 
activated platelets can start aggregation. The activation and aggregation potential is 
higher inside the recirculation zone due to longer retention time for platelets trapped 
inside and elevated local concentration of agonists released by platelets upon activation. 
These would lead to thrombus formation in the recirculation zone.  
 
 
 
  
Figure 47. Proposed thrombus formation mechanism. Quiescent platelets rolling 
inside oscillatory zone gets activated. Quiescent/activated platelets get trapped 
inside the recirculation zone with active EC and promote thrombus formation. 
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6.6.2 Regulatory Mechanism 
The EC-platelet interaction studies revealed a protective effect of platelets on EC 
under pathological shear stress. Here we propose two hypotheses for this protective 
mechanism. 
First, the protective mechanism could take place through certain substances 
released by activated platelets, inhibiting EC activation under pathological shear stress. 
The continuous convective mass transfer of biochemical factors, especially in medium to 
large sized blood vessels (such as the left coronary artery), would prevent the 
accumulation of such substances and reduce their local concentration. The only possible 
locations for EC-activation-inhibiting substance to accumulate are the recirculation 
zones. Further, most substances like ADP, thrombin and PDGF released by platelets are 
known to induce EC activation. The only substance known to be released by platelets that 
could potentially inhibit EC activation is plasminogen activator inhibitor – 1 (PAI-1)117. 
PAI-1 has been shown to play a major role in angiogenesis and cancer metastasis, but the 
effect of dynamic shear stress on PAI-1 is yet to be known. 
The second possible explanation is that this protective mechanism occurs through 
the direct physical contact between platelets and EC. Both EC (ICAM-1, vWF, PSGL-1 
and PECAM-1) and platelets (GPIbα, GPIIb/IIIa, P-selectin and PECAM-1) have a few 
surface proteins that are involved in anchoring of platelets to EC. On EC, though ICAM-
1, vWF and PSGL-1 enable platelet adhesion, they are not known to trigger any 
downstream signaling cascades. PECAM-1 is the only adhesion molecule that is known 
to form a mechanosensory complex along with VE-cadherin and VEGFR2
98
. This 
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junctional protein complex plays a key role in sensing flow. The cytoplasmic tail of 
PECAM-1 has been shown to be phosphorylated in response to shear stress
118
. 
Downstream, PECAM-1 activation triggers AKT/PI3K pathways
98
, which are involved in 
major shear induced responses including generation of ICAM-1. Also, on platelets, 
PECAM-1 has been recently shown to inhibit the GPIbα triggered activation of 
GPIIb/IIIa leading to firm adhesion or aggregation (Figure 48)
119;120
. Hence, PECAM-1 is 
a potential target that could be responsible for EC losing their sensitivity to shear stress 
and platelets gaining their sensitivity. Future experiments focused on assessing the 
activation and function of PECAM-1 on both EC and platelets might uncover a 
mechanosensing mechanism under pathological dynamic shear stress and reveal a 
potential therapeutic target. 
 
 
 
 
 
 
 
Figure 48. Proposed regulatory mechanism mediated through PECAM-1. EC and 
platelet surface PECAM-1 regulate internal functions of both the cell types and 
prevent firm adhesion, platelet activation and EC activation.  
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CHAPTER VII 
 
 
CONCLUSION AND FUTURE DIRECTIONS 
7.1 Summary 
The key observations from this study are summarized below: 
Under normal conditions, low magnitude bidirectional oscillatory shear zone 
formed near the LM bifurcation.  Under stenosis conditions (30%, 60% and 80%), flow 
separated near the stenosis with elevated shear stress developing at the stenosis throat. 
Zones with low magnitude unidirectional or oscillatory shear stress develop downstream 
of the stenosis. Endothelial cells could therefore experience low unidirectional pulsatile 
shear stress downstream of the stenosis, and these cells had a higher chance to get 
activated by flow. The inconsistence in surface protein expression, total protein 
expression and mRNA changes for factors tested in this study indicated that long duration 
shear exposure experiments are needed to investigate EC response to dynamic shear and 
their functional/physiological significance. On the other hand, EC present at the stenosis 
throat and exposed to high magnitude shear were not activated compared to those 
exposed to physiological levels of shear stress. This might indicate a potential inhibitory 
mechanism triggered by high magnitude shear stress.  
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As platelets travelled through the left anterior descending artery, they could be 
exposed to various shear stress conditions: physiological, low or elevated pulsatile shear 
stress. Platelet sensitivity to dynamic shear stress was not detected in terms of certain 
surface protein expression (data not shown in this study). However, proteomics analysis 
demonstrated that platelets expressed different proteomic patterns under various dynamic 
shear stress conditions. Platelets were also sensitive to differences in dynamic shear stress 
patterns in terms of complement activation. Platelets that were exposed to low magnitude 
unidirectional shear could initiate classical pathway complement activation (elevated C1q 
deposition). However, this activation could not proceed to completion due to the 
triggering of complement inhibitors.  
When platelets and EC were exposed to shear stress simultaneously, their cellular 
responses to dynamic shear stress changed. EC could not sense the difference between 
different dynamic shear stress patterns in the presence of platelets, at least in terms of cell 
activation, at both protein level and mRNA level. On the other hand, platelet sensitivity 
to various dynamic shear stress patterns increased. With the presence of EC, platelets 
exposed to pathological levels of shear stress (high and low) had an elevated activation 
level evidenced by their increased thrombin generation potential. These sensitized 
platelets when trapped inside the recirculation zone, due to the increased retention time, 
revealed an increased potential to adhere to injured endothelial cells or the blood vessel 
wall. It suggests that thrombosis and atherosclerotic lesion has a potential to grow 
towards the downstream region of an existing stenosis. 
The major goal of this study was to estimate physiological levels of shear stress in 
human left coronary artery and to examine the behavior of EC and platelets when 
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exposed to such forces. The novel approach of utilizing numerical simulations to guide in 
vitro experiments enabled us to understand the activation and inflammatory response of 
EC and platelets under physiologically realistic shear environments. In general, the 
findings from this study indicate that both EC and platelet responses are altered under 
disturbed shear stress conditions, especially their interaction. In addition, the low 
magnitude pulsatile shear stress was found to be more potent for EC and platelet 
activation, as well as their interaction, compared to the high magnitude pulsatile shear.  
7.2 Future Studies 
In the future, the numerical model could potentially be extended to incorporate 
biological responses like platelet-platelet interaction and platelet-vessel wall interaction. 
Biochemical responses like changes in protein concentration or increase in 
activation/adhesion potential could be modeled by incorporating the empirical results 
back into the CFD model. However, the major hurdle to realize such a model is the 
involvement of multiple length and time scales.  
As reported in the literature, EC ICAM-1 generation is controlled by a key 
mechanotransduction pathway – the MAP-Kinase pathway. Investigation of the effect of 
low magnitude pulsatile shear on this pathway could lead to a better understanding of EC 
activation and corresponding ICAM-1 generation. The discrepancies in the changes 
observed in endothelial cell mRNA and protein level indicate the need for further 
investigation under longer shearing durations.  
 Further, the proteomic analysis of platelets has revealed two potential protein 
targets (thymosin β4, Platelet Factor-4) which need to be further investigated. This may 
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lead to detection of potential platelet agonist specific biomarkers, which could have 
greater clinical implications.  
In addition, as reported in this study, in the presence of platelets EC lost their 
sensitivity to pulsatile shear stress. PECAM-1 is one of the major mechanosensory 
complex on EC, and has the ability to bind to PECAM-1 on platelet surface
118
. The cross 
talk between PECAM-1 molecules could potentially have led to EC losing sensitivity to 
pulsatile shear while platelets gained sensitivity. Hence, it will be interesting to 
investigate the effect of physiological and pathological levels of shear stress on PECAM-
1 expression and function.  
 
. 
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